Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

CURRICULUM VITAE

Peter L. Havens MD
Professor
Department of Pediatrics
Division of Infectious Disease

OFFICE ADDRESS:
Children's Corporate Center
999 N 92 St
Milwaukee, WI 53226

EDUCATION:
1975 - Present A.B., Cum Laude, Harvard College, Cambridge
1975 - Present AB - Cum Laude, Harvard College, Cambridge, MA
1980 - Present M.D., University of Missouri, School of Medicine, Kansas City
1980 - Present MD, University of Missouri, School of Medicine, Kansas City, MO
1987 - Present S.M., Harvard School of Public Health, Department of Epidemiology, Boston
1987 - Present SM, Harvard School of Public Health, Department of Epidemiology, Boston, MA

POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS:
1981 - Present Intern, Internal Medicine, Truman Medical Center, Kansas City, MO
1981 - 1987 Clinical Fellow, Pediatrics, Harvard Medical School, Boston, MA
1981 - 1984 Intern Junior Assistant Resident and Senior Assistant Resident in Pediatrics, Children's Hospital, Boston, MA
1981 - 1987 Clinical Fellow, Pediatrics, Harvard Medical School, Boston, Massachusetts
1981 - 1984 Intern, Junior Assistant Resident and Senior Assistant Resident in Pediatrics, The Children's Hospital, Boston, Massachusetts
1981 - Present Intern, Internal Medicine, Truman Medical Center, Kansas City, Missouri
1984 - 1987 Fellow, Pediatric Infectious Diseases, The Children's Hospital, Boston, Massachusetts
1984 - 1987 Fellow, Pediatric Infectious Diseases, Children's Hospital, Boston, MA
1985 - 1987 Fellow, Anesthesia (Intensive Care), The Children's Hospital, Boston, Massachusetts
1985 - 1987 Fellow, Anesthesia (Intensive Care), Children's Hospital, Boston, MA

FACULTY APPOINTMENTS:
1970 - Present National Merit Scholarship
1975 - Present Honors in Biology, Harvard University
1981 - Present Upjohn Award, University of Missouri, Kansas City, School of Medicine
1986 - Present Society of Critical Care Medicine
1987 - 1991 Assistant Professor, Pediatrics, Divisions of Critical Care and Infectious Diseases, Medical College of Wisconsin, Milwaukee, WI
1987 - 1993 Active participant in weekly seminar for graduate students in Department of Biostatistics and Clinical Epidemiology (Biostatistics 200)
1987 - 2000 Associate Director, Pediatric Intensive Care Unit, Children's Hospital of Wisconsin, Milwaukee, Wisconsin
1987 - Present Consultant in Pediatric Infectious Diseases, Children's Hospital of Wisconsin, Milwaukee, WI
1987 - Present American Board of Pediatrics, Certification in General Pediatrics
1987 - Present American Board of Pediatrics, sub-specialty certification in Pediatric Critical Care
1987 - Present Fellow, American Academy of Pediatrics
1987 - Present American Society for Microbiology
1987 - 1993 Physician Consultant to the Shorewood Health Board
1987 - Present Faculty Retreat Committee
1987 - 1991 Lab Space and Equipment Committee
1987 - 1988 Utilization and Quality Review Committee
1987 - 2006 Infection Control Committee
1987 - 1992 Drug Usage Review Committee
1987 - 1989 PL-3 Teaching Conferences, monthly
1987 - 2001 Daily lectures to residents when on call in PICU (to 1995) or Intermediate ICU (1996-2001).
1987 - 1991 Assistant Professor, Pediatrics, Medical College of Wisconsin, Wisconsin, Divisions of Critical Care and Infectious Diseases, Milwaukee
1988 - 1995 Director, Fellowship in Pediatric Critical Care Medicine, Children's Hospital of Wisconsin/Medical College, Wisconsin, Milwaukee, Wisconsin
1988 - Present Medical Microbiology Conference Group Leader
1988 - Present Pediatric Infectious Disease Society
1988 - Present Most Outstanding Teacher Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, Wisconsin
1989 - Present Most Outstanding Teacher Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, Wisconsin
1989 - 1993 Freshman Biostatistics Course (M1): Lecture on Infectious Diseases Epidemiology
1989 - 2001 Pharmacy and Therapeutics Committee
1990 - 2014 Infectious Diseases Consultant, Heart Transplantation Program, Children's Hospital of Wisconsin, Milwaukee, Wisconsin
1990 - Present Member, Milwaukee Metropolitan AIDS Planning Project, Provider Concerns Task Force
1990 - 1992 Shorewood Kickers Soccer Coach (under 6)
1990 - 2012 Research Methods Workshop Co-Director. Initially a course for Clinical Fellows and Medical College Faculty, has also been for Graduate Credit in Epidemiology since 1995. Given by members of the Departments of Pediatrics, Internal Medicine, and Family Medicine. 20-36 st
1990 - 1995 Nutritional Support Committee
1990 - 1996 Medical Records Steering Committee
1990 - 1991 Laboratory Advisory Committee
1991 - 1997 Associate Professor, Pediatrics and Epidemiology, Divisions of Critical Care and Infectious Diseases, Medical College of Wisconsin, Milwaukee, WI
1991 - Present Assistant Professor, Biostatistics/Clinical Epidemiology, Medical College of Wisconsin, Milwaukee, WI
1991 - Present Assistant Professor, Biostatistics/Clinical Epidemiology, Medical College of Wisconsin, Milwaukee, Wisconsin
1991 - 1997 Associate Professor, Pediatrics and Epidemiology, Medical College of Wisconsin, Wisconsin, Divisions of Critical Care and Infectious Diseases, Milwaukee
1991 - Present Director, Pediatric HIV Care Program, Children's Hospital of Wisconsin, Milwaukee, Wisconsin
1991 - Present Honor Roll of Outstanding Teachers, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, Wisconsin
1991 - 1992 Dean's Physical Medicine and Rehabilitation Task Force
1991 - 1995 Executive Committee, Pediatric Critical Care Study Group
1991 - 2004 City of Milwaukee Pediatric HIV Coordinating Committee
1991 - 1997 Steering Committee of the AIDS Coalition of Milwaukee
1991 - 1999 Milwaukee HIV Services Consortium
1991 - Present Established the Dr. Elaine Kohler Fund for Humanity in Medicine, a $250, 000 endowment for research in Pediatric Critical Care Medicine, with the Children's Hospital of Wisconsin Foundation.
1991 - Present Infectious Diseases Society of America
1992 - 1998 Chairman, Data Safety Monitoring Board, Randomized Trial of Early Dexamethasone versus Placebo for Prevention of Chronic Lung Disease in Neonates, Perinatal Foundation, Milwaukee, WI.
1992 - Present Enhanced the endowment for research in Pediatric Critical Care Medicine at the Children's Hospital of Wisconsin Foundation, as the Steigleider Trust contributed endowment funding of $125, 000 for research and education in Pediatric Critical Care.
1992 - 1995 SHARE WITH KIDS Program: Needs assessment for Pediatric/Adolescent HIV care program in Milwaukee, WI. Hemophilia-Pediatric AIDS Special Initiative, Maternal and Child Health Program Grant Number MCH-55HP52-01-0. $73, 000 yearly for 3 years ($219, 000 total granted). Janice Hand, Program Director; Kathleen Marquardt, Project coordinator; Dr Havens Medical Di
1992 - 1993 Graduate School advisor/ thesis Committee for Ramesh Sachdeva, candidate for Master of Science degree in Biostatistics/Clinical Epidemiology, MCW.
1992 - Present $6, 000 grant from the Pediatric AIDS Foundation to support the Pediatric HIV Care Program at Children's
1992 - Present Central Venous Line Complication Task Force
1992 - 1993 Central Venous Line Complication Committee Chair
1992 - Present Pediatric HIV Care Program funding, program for Children with Special Health Care Needs. $28, 000.
1993 - Present Wisconsin Maternal and Child Health Coalition Achievement Award: "Outstanding Sustained Public Information Program", along with all members of the Pediatric HIV Coordinating Committee of Milwaukee
1993 - Present Edward J. Lennon Endowed Clinical Teaching Award, Medical College of Wisconsin, Milwaukee, Wisconsin
1993 - Present Advanced Topics in Epidemiology (Biostatistics 202): Series on Infectious Diseases Epidemiology for Biostatistics/ Clinical Epidemiology Graduate course.
1993 - 1997 Received grant of $4, 000 yearly for 5 years from the Stackner Family Foundation to support the Pediatric HIV Care Program
1993 - Present Primary CARRE Project: Maternal and Child Health Bureau Pediatric/Adolescent HIV/AIDS Demonstration Project Grant for statewide program to enhance the care of HIV-infected patients in primary care se, 000 granted; Dr. Havens, medical director and co-primary investigator.
1994 - Present A.H. Robins / Wyeth-Ayerst Laboratories Miracle Maker Award for excellence in patient care, service to the community, and health education.
1994 - 1996 Graduate School advisor/ thesis committee for Alan Burkowsky, candidate for Master of Science degree in Epidemiology, MCW.
1994 - 1995 Chairman, Protocol Review Committee, Pediatric Critical Care Study Group.
1994 - Present Program Committee, Maternal and Child Health Bureau Meeting on HIV/AIDS Primary Care for Children and Families, Boston, MA.
1994 - Present Grants reviewer for Ryan White Title IV Planning and Initial Development Projects, Maternal and Child Health Bureau, Hemophilia and AIDS Program Branch, Rockville, MD
1994 - Present Scientific Committee, Seventh Pediatric Critical Care Colloquium, Seattle, WA
1994 95 Society of Critical Care Medicine Awards Committee
1994 - 1995 Co-Chair, Workgroup on Perinatal Transmission of HIV, Tertiary Care Committee of the Wisconsin Association of Perinatal Care, Madison, WI
1994 - Present Pelz family endowment of $25, 000 to support the Pediatric HIV Care Program at Children's Hospital of Wisconsin. Multiple other C
1994 - Present Wisconsin HIV Primary Care Support Network for Children, Adolescents, and Families. Maternal and Child Health Bureau Pediatric/Adolescent HIV/AIDS Demonstration Project Grant for statewide program to enhance the care of HIV-infected patients in primary care settings th, 000 granted; Dr. Havens, medical director and co-primary investigator.
1994 - Present Department of Preventive Medicine Chairman Search Committee
1994 - 1999 Epidemiology Graduate Program Committee
1994 - 1999 Health Policy Institute Executive Committee
1994 - 1996 Central Venous Line Quality Improvement Task Force Co-Chair
1994 - Present Weekly attendance at PL-3 "Senior Rounds" teaching conference (twice weekly since 2008).
1994 - Present Society for Epidemiologic Research
1995 - 1997 Director, Research Education, Fellowship in Pediatric Critical Care Medicine, Children's Hospital of Wisconsin/Medical College, Wisconsin, Milwaukee, Wisconsin
1995 - Present American Board of Pediatrics, sub-specialty certification in Pediatric Infectious Diseases
1995 - Present American Board of Pediatrics, re-certification in Pediatric Critical Care
1995 - Present E. Grey Dimond, M.D. Take Wing Award, for "...exceptional professional or personal accomplishments that contribute to the field of medicine..." University of Missouri-Kansas City School of Medicine,, MO.
1995 - Present Teaching Excellence Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, Wisconsin
1995 - Present Outcome Evaluation Workgroup, Ryan White Title IV Program, Maternal and Child Health Bureau, Rockville, MD
1995 - 1996 Co-Chair, Wisconsin Statewide Workgroup on HIV Education and Testing in the Perinatal Period, Madison WI.
1995 - 1998 Nicolet Kickers Soccer Coach
1995 - Present Primary Prevention of Developmental Disabilities Grant to educate providers and consumers about prevention of HIV infection in children. $5, 000 grant total.
1995 - 1996 State of Wisconsin HIV/AIDS Program contract to perform statewide teaching/training concerning recommendations for universal counseling and HIV testing for pregnant women in the state of Wisconsin. $, 000 grant total. Principal investigator.
1995 - 1996 Children's Hospital of Wisconsin Foundation Grant $10, 850 for Family Satisfaction Project, to measure the perception of care delivery by families enrolled in the HIV Primary Care Support Network. Co-principal investigator.
1995 - 1998 Wisconsin HIV Primary Care Support Network. Maternal and Child Health Bureau Pediatric/Adolescent HIV/AIDS Demonstration Project Grant for statewide program to enhance the care of HIV-infected patien, 000 granted yearly for 3 years; Dr. Havens, medical director and co-principal investigator.
1995 - 2002 Department of Pediatrics Research Committee
1995 - 2000 PL-3 Journal Club adviser
1995 - 2011 Research Methods Workshop (see below)
1995 - Present Infectious Diseases Epidemiology Graduate Seminar (Epi 270: 1 credit). Graduate Program in Epidemiology, Medical College of Wisconsin.
1995 - 1997 Graduate School advisor/ thesis committee for Kay Sichting, candidate for Master of Science degree in Epidemiology, MCW.
1995 - 1998 Active participant in weekly seminar for graduate students in the Health Policy Institute graduate program in Epidemiology.
1996 - 1997 Chair, Data Safety/Monitoring Board, Partial Liquid Ventilation Pediatric Multicenter Study, Alliance Pharmaceuticals, San Diego, CA
1996 - 1999 Bureau of Health Professions General Internal Medicine/General Pediatrics Faculty Development Grant. Dr. Havens receives $4, 000 support for teaching principles of Epidemiology and Clinical Research to faculty in Internal Med
1996 - Present General Pathology Course (Pathology 200) lecture on Infectious Diseases Epidemiology.
1996 - Present Member, Ryan White Title IV Annual Meeting Planning Committee, Maternal and Child Health Bureau, Hemophilia and AIDS Program Branch, Rockville, MD
1996 - 1997 Member, Working Group on Antiretroviral Therapy and Medical Management of Children with HIV Infection, National Pediatric and Family HIV Resource Center, Newark, NJ
1996 - 1999 Medical College of Wisconsin Faculty Development Program, Lecture series on Conducting Clinical Research, to Faculty in Pediatrics, Family and Community Medicine, and General Internal Medicine.
1996 - Present Consulting Faculty, University of Rhode Island Pharmacy Practitioner Education Program
1996 - 1998 Member, Data Safety/Monitoring Board, Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease, Vermont-Oxford Neonatal Network
1996 - Present Member, Special Review Committee for Pediatric AIDS Clinical Trials Group RFA AI-96-001, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Washington, D.C.
1997 - 1998 State of Wisconsin/Centers for Disease Control and Prevention Enhanced HIV/AIDS Surveillance Project for Pregnant Women and Children. Principal investigator. $135, 000 yearly grant total.
1997 - 1999 Graduate School advisor/ thesis committee for Matthew Scanlon, M.D., candidate for Master of Science degree in Epidemiology, MCW.
1997 - Present Infectious Diseases Epidemiology Graduate Seminar (Epi 270: 1 credit). Graduate Program in Epidemiology, Medical College of Wisconsin.
1997 - Present Thesis Committee for Cheryl Flynn, M.D., candidate for Master of Science degree in Epidemiology, MCW.
1997 - 2001 Member, Executive Committee and Board of Trustees, HIV Quality Care Network of the Infectious Diseases Society of America
1997 - Present Member, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Special Emphasis Panel for RFP NIH-NIAID-DAIDS-98-05, Statistical and Clinical Coordinating Center for the Women and Infants Transmission Study.
1997 - Present Member, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Special Emphasis Panel for PA-AI-DAIDS-96-004, Women and Infants Transmission Study.
1997 - Present Medical College of Wisconsin Society of Teaching Scholars
1997 - Present Award for Innovation, Association for Care of Children's Health (ACCH), honorable mention, with other members of the Wisconsin HIV Primary Care Support Network
1997 - 1998 Co-Director, Research Education, Fellowship in Pediatric Critical Care Medicine, Children's Hospital of Wisconsin/Medical College of Wisconsin, Milwaukee, Wisconsin
1997 - Present Professor, Pediatrics and Population Health (before 2006 = Epidemiology), Medical College of Wisconsin, Milwaukee, WI (with tenure, July, 2000)
1997 - Present Professor, Pediatrics and Population Health (before 2006 = Epidemiology), Medical College of Wisconsin, Milwaukee, WI
1997 - 1998 Interim Board of Directors, Pediatric/Children's Specialty Group
1998 - 1999 Designing Clinical Research: A Short Course. Series of 6 lecture and discussion sessions for faculty in Pediatric Critical Medicine and Pediatric Emergency Medicine.
1998 - 2001 Ryan White CARE Act Title IV grant to support the WI HIV Primary Care Support Network: $405, 443 yearly for 3 years. Medical director.
1998 - 2012 Board of Directors, Pediatric Specialty Group (PSG) then Children's Specialty Group (CSG)
1998 - 2006 Billing and Collections Subcommittee of the PSG/CSG
1998 - 2003 Academic Fellowship in Primary Care Research (National Research Service Award): Program steering committee and research faculty.
1999 - 2001 Ryan White CARE Act Title IV supplemental grant to support the WI HIV Primary Care Support Network: $75, 000 yearly for 2 years. Medical director.
1999 - 2001 African American Children's Initiative grant to support the WI HIV Primary Care Support Network: $95, 000.
1999 - Present Thesis Committee for Raj Nijhawan, M.D., candidate for Master of Science degree in Epidemiology, MCW.
1999 - 2008 Committee on Pediatric AIDS, American Academy of Pediatrics (AAP COPA).
1999 - Present Member, Clinical Guidelines Task Force, WI., Wisconsin Antibiotic Resistance Network. Marshfield Clinic and Wisconsin State Division of Health, Madison
2000 - Present Milwaukee Magazine: One of the Best Physicians in Milwaukee
2000 - 2001 Ryan White CARE Act Title II Grant to support the WI HIV Primary Care Support Network. $109, 603 yearly. Medical Director
2000 - Present Chair, Interim Study Monitoring Committee, Pediatric AIDS Clinical Trials Group Study 247
2000 - Present Department of Health and Human Services (DHHS) Panel on Antiretroviral Therapy and Medical Management of HIV-Infected Children--A Working Group of the Office of AIDS Research Advisory Council (OARAC)
2000 - Present Thesis Committee for Yolanda Rainge, M.D., candidate for Master of Science degree in Epidemiology, MCW.
2000 - 3 Graduate School advisor/ thesis committee for Kelly Skoumal (Tieves), M.D., candidate for Master of Science degree in Epidemiology, MCW.
2001 - 2006 Once or twice monthly lectures on infectious diseases topic to residents and medical students on Intermediate ICU rotation
2001 - 2003 Ryan White CARE Act Title IV grant to support the WI HIV Primary Care Support Network: $663, 873 yearly for 3 years. Second year $746, 436. Third year $856, 276. Medical director - 10% fu effort
2001 - 2002 Chair, Study Monitoring Committee, Pediatric AIDS Clinical Trials Group Study 247
2001 - 2002 Co-Chair, Workgroup on Perinatal Transmission of HIV, Tertiary Care Committee of the Wisconsin Association of Perinatal Care, Madison, WI
2001 - 2015 Preceptor for college students in the SPUR program, one per year
2001 - 2003 Invited Lecturer and Consultant, CDC Smallpox Preparedness and Response Training
2001 - 2003 Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network: $109, 603 yearly. Medical director
2001 - Present American Board of Pediatrics, re-certification in Pediatric Infectious Diseases
2001 - Present American Board of Pediatrics, re-certification in Pediatric Critical Care
2002 - Present Included in "Best Doctors in America"
2002 - Present "HIV Treaters Conference". Organized for practitioners caring for persons with HIV infection throughout southeastern WI: a monthly meeting to present cases and discuss issues in HIV treatment. Initi, and by 2012 also included sites in La Crosse and more sites in Madison and Milwaukee.
2002 - 2016 Member, Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention
2002 - Present Wisconsin Chapter, American Academy of Pediatrics "2002 Pediatrician of the Year"
2002 - 2003 Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention. NIH grant number: U01 HD40533-02. $32.976
2003 - 2015 Children's Specialty Group: Finance Committee (co-chair 2003-2006)
2003 - 2004 Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network: $86, 080. Medical director - 2.16% funded effort
2003 - 2004 Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention. NIH grant number: U01 HD40533-03. $36, 655 - 10% funded effort
2003 - 2004 Pediatric AIDS Clinical Trials Group. Affiliate of the Children's Memorial Hospital (Chicago) PACTU. NIH grant number U01-AI041089 - 3% funded effort, 8% unfunded effort
2003 - 2015 Children's Specialty Group Contracting Committee member
2004 - 2005 Rank and Tenure Committee
2004 - 2007 Ryan White CARE Act Title IV grant to support the WI HIV Primary Care Support Network: $856, 276 yearly for 3 years. Medical director - 10% funded effort
2004 - 2005 Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention. NIH grant number: U01 HD40533-04. $38, 009 - 10% funded effort
2004 - 2005 Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network: $86, 080. Medical director - 1.42% funded effort
2004 - 2008 Protocol Chair, Pediatric AIDS Clinical Trials Group study P1038: "A phase I/II Safety, Tolerability, and pharmacokinetic study of high dose lopinavir/ritonavir with or without saquinavir in HIV infec, 2004
2004 - 2009 "Pediatric HIV Treaters Conference". Organized with Dr. Laura Hoyt (Minneapolis) and MATEC-Minnesota. Monthly case presentations via telephone for practitioners caring for children and adolescents w, IA). We developed the data presentation software for the calls. I participate monthly
2004 - 2005 Pediatric AIDS Clinical Trials Group. Affiliate of the Children's Memorial Hospital (Chicago) PACTU. NIH grant number U01-AI041089 - 3% funded effort, 8% unfunded effort
2004 - 2005 Innovation Task Force: Co-chair of Patient Care Group and Chair of Co-chairs groups
2005 - Present Centers for Disease Control and Prevention Consultation on Pediatric HIV Case Definition, Rapporteur
2005 - 2006 Ad-Hoc Committee on the Fourth Pathway
2005 - 2006 Thesis committee for Noah Leigh, candidate for Master of Science degree in Epidemiology, MCW
2005 - 2011 Scholarship oversight committees for fellows in Critical Care, Neonatology, Cardiology, Emergency Medicine
2005 - Present Pediatric HIV Treaters' Data Collection Presentation Template. Midwest AIDS Training & Education Center, University of Illinois at Chicago grant number 5 H4AHA00062-03, $6, 260.
2005 - 2007 Protocol Chair, Adolescent Trials Network study 056, "Pharmacokinetics of once daily antiretroviral therapy regimens containing tenofovir and atazanavir/ritonavir in adolescents and young adults with, 498. 10% funded effort
2005 - 2006 Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network: $89, 402. Medical director - 1.38% funded effort
2005 - Present Department of Pediatrics Promotions Committee
2005 - 2006 Preventing Perinatal HIV Transmission-Wisconsin Provider Education Series. March of Dimes-Wisconsin Chapter Community Award, $16, 663.
2005 - 2006 Pediatric AIDS Clinical Trials Group. Affiliate of the Children's Memorial Hospital (Chicago) PACTU. NIH grant number U01-AI041089 - $11, 250, 2.87% funded effort
2005 - 2006 Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention. NIH grant number U01 HD40533-05 $21, 325 - 5% funded effort
2005 - Present AIDS Resource Center of Wisconsin "Twenty Giving Twenty" award, for service to children and families with HIV in Wisconsin.
2005 - Present "Clinician's Clinician, " for clinical excellence, voted by the faculty of the Department of Pediatrics, Medical college of Wisconsin
2005 - Present Most Outstanding Teacher Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, Wisconsin
2005 - Present Consultant, Center for International Health Pediatric HIV Training Program, Kenya
2006 - 2007 Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network: $150, 600. Medical director - 5% funded effort
2006 - 2016 Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention (ATN). NIH grant number U01 HD40533-05. 10% funded effort
2006 - 2011 Executive Committee, Department of Pediatrics
2006 - Present Data Safety Monitoring Board, Children's Hospital of Wisconsin
2006 - Present Consultant, Center for International Health Pediatric HIV Pharmacy Training Program, Zambia
2006 - 2007 Department of Population Health, Chair search committee member
2006 - 2009 Antiviral Drugs Advisory Committee, Food and Drug Administration, Rockville, MD
2007 - 2008 Thesis committee for Rupali Fuldeore, candidate for Master of Science degree in Epidemiology, MCW
2007 - 2008 Ryan White CARE Act Part D expansion grant to support revisions to data system of the WI HIV Primary Care Support Network: $74, 981 for 1 year. Medical director - 2.8% funded effort
2007 - 2010 Protocol Chair, Adolescent Trials Network study 063, "A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D Supplement to Improve Tubular Reabsorption of Ph, 560. 10% funded effort.
2007 - 2012 Ryan White CARE Act Part D grant to support the WI HIV Primary Care Support Network: $847, 712 yearly for 5 years. Medical director - 1.1% funded effort
2007 - 2012 Ryan White CARE Act Part B grant to support the WI HIV Primary Care Support Network: $210, 600. Medical director - 4.5% funded effort
2007 - Present AIDS Resource Center of Wisconsin award for leadership, for role in programs for prevention of mother to child transmission of HIV in Wisconsin
2007 - Present Presidential Volunteer Award, US Agency for International Development (USAID) for work in the Pediatric ART Centers of Excellence, Lusaka and Livingstone, Zambia
2007 - Present Lecturer for Centers for Disease Control (CDC) Training conference in Pediatric and Perinatal HIV, St. Petersburg, Russia, March 18-23, 2007
2007 - 8 Consultant, Roche Pharmaceuticals, Nelfinavir-EMS contamination June 2007 and June 2008
2007 - 2010 Consultant and lecturer, Center for International Health Pediatric HIV Pharmacy Training Program, Lusaka and Livingstone, Zambia
2007 - Present Reviewer, NICHD Pediatric and Perinatal HIV Studies Network site proposals, Rockville, MD.
2008 - Present Centers for Disease Control and Prevention Consultation on Prevention of Mother to Child Transmission of HIV in the United States, Participant, April 1-3, 2008.
2008 - Present American Board of Pediatrics, re-certification in Pediatric Infectious Diseases
2008 - 2009 Ryan White CARE Act Part D expansion grant to support electronic connections of outside laboratory data to the revised data system of the WI HIV Primary Care Support Network: $74, 981 for 1 year. Medical director - 2.8% funded effort
2008 - 2009 Department of Population Health, Chair search committee member
2008 - Present Translational scientific peer review panel, CTSI/AHW grants, MCW
2009 - Present Most Outstanding Teacher Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, Wisconsin
2010 - Present Children's Research Institute Clinical Effectiveness Research Task Force
2010 - 2011 Centers for Disease Control Elimination of Mother-to-Child HIV Transmission in the United States National Stakeholders' Research Working group
2010 - Present Global Health Advisory Committee
2011 - Present Centers for Disease Control Pediatric HIV Case Definition Revision working Group
2011 - 2012 Protocol chair, Adolescent Trials Network study "Fibroblast Growth Factor 23 relationships to Parathyroid Hormone, Vitamin D, Calcium, and Phosphate", a sub-analysis of ATN 063. $77, 658. 3% funded effort.
2011 - Present Downtown Health Center Working Group Chair
2011 - Present Consultant, "Tenofovir use in children and Adolescents, World Health Organization, Pediatric Antiretroviral Working Group, Geneva, Switzerland.
2011 - Present Electronic Health Record transition committees and data/records committees
2011 - 2013 Interim Vice-Chair, Department of Pediatrics
2012 - 2014 Central Funds Workgroup of the Institutional Financial Advisory Committee
2012 - 2016 Protocol Chair, Adolescent Trials Network Study 117 "Renal, Endocrine, and Bone Changes in Response to Treatment with Coformulated Emtricitabine - Tenofovir for Pre-Exposure HIV Prophylaxis (PrEP) in, 941. 10% funded effort.
2012 - 2017 Protocol Chair, Adolescent Trials Network study 109 "A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Effectiveness of Vitamin D3 50, 000 IU Every 4 weeks to Increase Bone Mineral Density and Decrease Tenofovir-Induced Hyperparathyroi, 282, 191. 10% funded effort.
2012 - 2017 Ryan White CARE Act Part B grant to support the WI HIV Primary Care Support Network: $200, 000. Medical director - ≈4% funded effort
2012 - Present National Quality Forum 2012 Infectious Diseases Endorsement Maintenance Project Steering Committee (nominated by Health Resources and Services Administration)
2012 - 2015 Ryan White CARE Act Part D grant to support the WI HIV Primary Care Support Network: $847, 713 yearly for 3 years. Medical director - 4-5% funded effort
2012 - 2014 Protocol chair, Adolescent Trials Network study "Effect of Vitamin D Treatment on Soluble Mediators of Inflammation: ATN 063 Further Laboratory Studies and Analysis", a sub-analysis of ATN 063. $180, 670. 5% funded effort.
2012 - Present 18th International AIDS Conference abstract reviewer
2013 - Present Most Outstanding Teacher of the Full Time Faculty, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin, Milwaukee, Wisconsin
2013 - Present Children's Specialty Group Physician's Assistant Excellence Award Review Committee
2013 - Present Department of Pediatrics Scholarly Activity Committee chair
2013 - Present Children's Specialty Group Workforce and Position Review Committee member
2013 - Present Vice-Chair, Department of Pediatrics
2013 - Present NIAID/NIH RFA AI-12-018: Clinical Trial Unit for NIAID Networks. Peer Review Panel Member
2014 - Present Clinton Health Access Initiative (CHAI) Tenofovir disoproxil fumarate (xb) Program, Clinical Advisory Board, Member
2014 - Present 20th International AIDS Conference abstract reviewer
2014 - Present Centers for Disease Control and Prevention, Guidelines for antiretroviral post-exposure prophylaxis after sexual, injection drug use, or other non-occupational exposure to HIV. Consultant
2014 - Present NICHD/NIH 2015/01 ZRG1 AARR-F (45) Program Project: AIDS and AIDS Related Research. Peer Review Panel Member
2014 - Present Center for International Health Program Advisory Committee
2014 - Present Children's Research Institute Grants reviewer
2015 - 2017 Ryan White CARE Act Part D grant to support the WI HIV Primary Care Support Network: $847, 713 yearly for 3 years. Medical director - 4-5% funded effort
2015 - Present NICHD/NIH 2015/01 ZRG1 AARR-F (45) Program Project: AIDS and AIDS Related Research. Peer Review Panel Chair
2015 - Present NIH 2016/01 ZRG! AARR-G (54) R Special Emphasis Panel/Scientific Review group member
2015 - Present Consultant, Clinical Consultation Center Perinatal HIV Hotline and HIV/AIDS Management Hotline, University of California, San Francisco (HRSA subcontract). 5% funded effort
2015 - Present International AIDS Society Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) grants reviewer
2016 - Present Food and Drug Administration Pediatric Advisory Committee Meeting April 12, 2016, Invited Expert Consultant
2016 - 20/5 ZHD1 DSR-A (52) 1: National Institute of Child Health and Human Development Special Emphasis Panel member
2016 - Present International AIDS Society Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) grants reviewer
2016 - Present Expert Clinician award (top 10% of clinicians by peer survey), Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
2016 - Present Expert Teacher award (top 10% of teachers by peer, community provider, and learner survey), Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI
2016 - Present Department of Pediatrics Genetics Section Chief Search Committee
2016 - 2018 CDC-HRSA Advisory Committee (CHAC), member, appointed at the request of HRSA.
2016 - 2020 FDA Pediatric Advisory Committee, member, appointed at the request of the FDA
Hospital and Administrative Appointments:
Less formal teaching relationships, not associated with a specific degree program or trainee group, are not reported, or are reflected in lists of presentations or manuscripts.
Licensure:
Massachusetts and Wisconsin (WI - #28368)
Awards, Honors:
Memberships in Professional and Honorary Societies:
Manuscripts Reviewed for:
Pediatric Research
Clinical Pediatrics
Western Journal of Medicine
Journal of Intensive Care Medicine
Journal of the American Medical Association
Clinical Infectious Diseases
Pediatric Dermatology
Consultant
Journal of Pediatrics
Pediatrics
Pediatric Infectious Diseases Journal
International Advisory Committees and/or Activities
National Advisory Committees and/or Activities
- 1999 Member, 1999-2008
Chair, July 2004 to June 2008.
Member from 2000
Co-chair, 2003 to 2006
Co-Chair, 2006 (December) to 2016.
- 2016 Chair, 2016 (Jan) to present
State Advisory Committees and/or Activities
Community Advisory Committees or Activities
Grants and Contracts: Present Support
Grants and Contracts: Past Support
Lectures and Site Visits:
Extramural Invited Lectures Outside Wisconsin, Extramural Invited Lectures in Wisconsin, and Intramural Lectures: see Appendix
Medical College Committees -- College-wide:
Medical College Committees -- Department of Pediatrics:
Hospital or Health System Committees:
Medical College Teaching -- Medical Students or Pre-Medical Students:
Medical College Teaching -- Residents:
Medical College Teaching -- Epidemiology Graduate Students:
Medical College Teaching -- Fellows and Faculty:
Medical College Teaching -- Community:
Specialty Certification:

HOSPITAL AND CLINICAL ADMINISTRATIVE APPOINTMENTS:
1987 - 2000 Associate Director, Pediatric Intensive Care Unit, Children's Hospital of Wisconsin, Milwaukee, WI
1987 - Present Consultant in Pediatric Infectious Diseases, Children's Hospital of Wisconsin, Milwaukee, WI
1988 - 1995 Director, Fellowship in Pediatric Critical Care Medicine, Children's Hospital of Wisconsin/Medical College, Milwaukee, WI
1990 - Present Infectious Diseases Consultant, Heart Transplantation Program, Children's Hospital of Wisconsin, Milwaukee, WI
1991 - Present Director, Pediatric HIV Care Program, Children's Hospital of Wisconsin, Milwaukee, WI
1995 - 1997 Director, Research Education, Fellowship in Pediatric Critical Care Medicine, Children's Hospital of Wisconsin/Medical College, Milwaukee, WI
1997 - 1998 Co-Director, Research Education, Fellowship in Pediatric Critical Care Medicine, Children's Hospital of Wisconsin/Medical College of Wisconsin, Milwaukee, WI

SPECIALTY BOARDS AND CERTIFICATION:
Certificates
Issued By Issue DateExpiration
American Board of Pediatrics
Certification in General Pediatrics
1987
None
American Board of Pediatrics
1987
None
American Board of Pediatrics
sub-specialty certification in Pediatric Infectious Diseases
1995
None
American Board of Pediatrics
re-certification in Pediatric Critical Care
1995
None
American Board of Pediatrics
re-certification in Pediatric Critical Care
2001
None
American Board of Pediatrics
re-certification in Pediatric Infectious Diseases
2001
None
American Board of Pediatrics
re-certification in Pediatric Infectious Diseases
2008
None
 

Licensure
Number Issue DateExpiration
Massachusetts License
#28368
None
 

AWARDS AND HONORS:
1970 - Present National Merit Scholarship
1975 - Present Honors in Biology, Harvard University
1981 - Present Upjohn Award, University of Missouri, Kansas City, School of Medicine
1988 - Present Most Outstanding Teacher Award, Medical College of Wisconsin and Children's Hospital of Wisconsin
1989 - Present Most Outstanding Teacher Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin
1991 - Present Honor Roll of Outstanding Teachers, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin
1993 - Present Edward J. Lennon Endowed Clinical Teaching Award, Medical College of Wisconsin
1993 - Present Wisconsin Maternal and Child Health Coalition Achievement Award: "Outstanding Sustained Public Information Program", Pediatric HIV Coordinating Committee of Milwaukee
1994 - Present A.H. Robins / Wyeth-Ayerst Laboratories Miracle Maker Award for excellence in patient care, service to the community, and health education
1995 - Present Teaching Excellence Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin
1995 - Present E. Grey Dimond, M.D. Take Wing Award, for "...exceptional professional or personal accomplishments that contribute to the field of medicine...” , University of Missouri-Kansas City School of Medicine
1997 - Present Award for Innovation, Association for Care of Children's Health
1997 - Present Society of Teaching Scholars, Medical College of Wisconsin
2000 - Present One of the Best Physicians in Milwaukee, Milwaukee Magazine
2002 - Present 2002 Pediatrician of the Year, Wisconsin Chapter, American Academy of Pediatrics
2003 - 2008 Best Doctors in America
2005 - Present Most Outstanding Teacher Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin
2005 - Present “Twenty Giving Twenty” award, for service to children and families with HIV in Wisconsin, AIDS Resource Center of Wisconsin
2005 - Present “Clinician’s Clinician,” for clinical excellence, Department of Pediatrics, Medical college of Wisconsin
2007 - Present Presidential Volunteer Award, US Agency for International Development (USAID) for work in the Pediatric ART Centers of Excellence, Lusaka and Livingstone, Zambia
2007 - Present AIDS Resource Center of Wisconsin award for leadership
2009 - Present Most Outstanding Teacher Award, Pediatric House Staff, Medical College of Wisconsin and Children's Hospital of Wisconsin

MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES:
1986 - Present Society of Critical Care Medicine (Member)
1987 - Present American Society for Microbiology (Member)
1987 - Present American Academy of Pediatrics (Fellow)
1988 - Present Pediatric Infectious Disease Society (Member)
1991 - Present Infectious Diseases Society of America (Member)
1994 - Present Society for Epidemiologic Research (Member)

EDITORSHIPS/EDITORIAL BOARDS/JOURNAL REVIEWS:
Journal Review
Western Journal of Medicine
Consultant
Journal of Intensive Care Medicine
Journal of Pediatrics
Journal of the American Medical Association
Pediatric Dermatology
Clinical Pediatrics
Clinical Infectious Diseases
Pediatric Research
Pediatrics

LOCAL/REGIONAL APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1987 - 1991 Member, Lab Space and Equipment Committee, Medical College of Wisconsin
1987 - Present Member, Faculty Retreat Committee, Medical College of Wisconsin
1991 - 1992 Member, Dean's Physical Medicine and Rehabilitation Task Force, Medical College of Wisconsin
1994 - 1999 Member, Epidemiology Graduate Program Committee, Medical College of Wisconsin
1994 - 1999 Member, Health Policy Institute Executive Committee, Medical College of Wisconsin
1994 - 1995 Co-Chair, Workgroup on Perinatal Transmission of HIV, Tertiary Care Committee, Wisconsin Association of Perinatal Care
1994 Member, Search Committee, Medical College of Wisconsin, Department of Preventive Medicine Chairman
1995 - 2002 Member, Department of Pediatrics Research Committee, Medical College of Wisconsin
1995 - 1996 Co-Chair, Wisconsin Statewide Workgroup, HIV Education and Testing in the Perinatal Period
1997 - 1998 Member, Interim Board of Directors, Pediatric/Children's Specialty Group, Medical College of Wisconsin
1998 - 2006 Chair, Billing and Collections Subcommittee of the PSG/CSG, Medical College of Wisconsin
1998 - Present Member, Board of Directors, Pediatric Specialty Group (PSG) then Children’s Specialty Group (CSG), Medical College of Wisconsin
1999 Member, Clinical Guidelines Task Force, Wisconsin Antibiotic Resistance Network. Marshfield Clinic and Wisconsin State Division of Health
2001 - 2002 Co-Chair, Workgroup on Perinatal Transmission of HIV, Tertiary Care Committee, Wisconsin Association of Perinatal Care
2003 - 2006 Co-Chair, Finance Committee, Children’s Specialty Group, Medical College of Wisconsin
2004 - 2005 Member, Rank and Tenure Committee, Medical College of Wisconsin
2004 - 2005 Co-chair of Patient Care Group and Chair of Co-chairs groups, Innovation Task Force, Medical College of Wisconsin
2005 - 2006 Member, Ad-Hoc Committee on the Fourth Pathway, Medical College of Wisconsin
2005 - Present Member, Department of Pediatrics Promotions Committee, Medical College of Wisconsin
2006 - Present Member, Executive Committee, Medical College of Wisconsin Department of Pediatrics-Faculty Representative
2006 - 2007 Member, Chair search committee, Medical College of Wisconsin, Department of Population Health
2008 - 2009 Member, Chair search committee, Medical College of Wisconsin, Department of Population Health
2008 Member, Translational scientific peer review panel, CTSI/AHW grants, MCW
2010 - Present Member, Children’s Research Institute Clinical Effectiveness Research Task Force, Medical College of Wisconsin
2010 Member, Global Health Advisory Committee, Medical College of Wisconsin

NATIONAL ELECTED/APPOINTED LEADERSHIP AND COMMITTEE POSITIONS:
1991 - 1995 Member, Executive Committee, Pediatric Critical Care Study Group
1992 - 1998 Chairman, Data Safety Monitoring Board, Randomized Trial of Early Dexamethasone versus Placebo for Prevention of Chronic Lung Disease in Neonates, Perinatal Foundation
1994 - 1995 Chairman, Protocol Review Committee, Pediatric Critical Care Study Group
1994 Member, Scientific Committee, Seventh Pediatric Critical Care Colloquium
1994 - 1995 Member, Awards Committee, Society of Critical Care Medicine
1994 Grants reviewer, Ryan White Title IV Planning and Initial Development Projects, Maternal and Child Health Bureau, Hemophilia and AIDS Program Branch
1994 Member, Program Committee, Maternal and Child Health Bureau Meeting on HIV/AIDS Primary Care for Children and Families
1995 Member, Outcome Evaluation Workgroup, Ryan White Title IV Program, Maternal and Child Health Bureau
1996 - 1997 Member, Working Group on Antiretroviral Therapy and Medical Management of Children with HIV Infection, National Pediatric and Family HIV Resource Center
1996 - 1997 Chair, Data Safety/Monitoring Board, Partial Liquid Ventilation Pediatric Multicenter Study, Alliance Pharmaceuticals
1996 Member, Special Review Committee for Pediatric AIDS Clinical Trials Group RFA AI-96-001, National Institutes of Health, National Institute of Allergy and Infectious Diseases
1996 Member, Ryan White Title IV Annual Meeting Planning Committee, Maternal and Child Health Bureau, Hemophilia and AIDS Program Branch
1996 - 1998 Member, Data Safety/Monitoring Board, Early Postnatal Dexamethasone Therapy for the Prevention of Chronic Lung Disease, Vermont-Oxford Neonatal Network
1996 - Present Member, Consulting Faculty, University of Rhode Island Pharmacy Practitioner Education Program
1997 Member, Statistical and Clinical Coordinating Center for the Women and Infants Transmission Study, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Special Emphasis Panel for RFP NIH-NIAID-DAIDS-98-05
1997 - 2001 Member, Executive Committee and Board of Trustees, HIV Quality Care Network of the Infectious Diseases Society of America
1997 Member, Special Emphasis Panel for PA-AI-DAIDS-96-004, Women and Infants Transmission Study, National Institutes of Health, National Institute of Allergy and Infectious Diseases
1999 - 2008 Member, Committee on Pediatric AIDSCOPA), American Academy of Pediatrics (AAP COPA)
2000 - Present Member, Pediatric Antiretroviral Therapy Writing Committee, a subgroup of the Working Group on Antiretroviral Therapy and Medical Management of Children with HIV Infection, NIH, HRSA, and the National Pediatric and Family HIV Resource Center, Newark, NJ
2000 Chair, Interim Study Monitoring Committee, Pediatric AIDS Clinical Trials Group Study 247
2001 - 2002 Chair, Study Monitoring Committee, Pediatric AIDS Clinical Trials Group Study 247
2002 - Present Member, Therapeutic Leadership Group of the Adolescent Medicine Leadership Group, Adolescent Medicine Trials Network for HIV/AIDS Intervention
2003 - Present Co-Chair, Pediatric Antiretroviral Therapy Writing Committee, a subgroup of the Working Group on Antiretroviral Therapy and Medical Management of Children with HIV Infection, NIH, HRSA, and the National Pediatric and Family HIV Resource Center, Newark, NJ
07/2004 - 06/2008 Chair, Committee on Pediatric AIDS, American Academy of Pediatrics (AAP COPA)
2005 Consultant, Center for International Health Pediatric HIV Training Program, Kenya
2005 Centers for Disease Control and Prevention Consultation on Pediatric HIV Case Definition, Rapporteur
2006 - 2009 Member, Antiviral Drugs Advisory Committee, Food and Drug Administration
2006 Consultant, Center for International Health Pediatric HIV Pharmacy Training Program, Zambia
06/2007 - 06/2008 Consultant, Nelfinavir-EMS contamination, Roche Pharmaceuticals
2007 Reviewer, NICHD Pediatric and Perinatal HIV Studies Network site proposals
04/01/2008 - 04/03/2008 Participant, Centers for Disease Control and Prevention Consultation on Prevention of Mother to Child Transmission of HIV in the United States
2010 - 2011 Member, National Stakeholders’ Research Working group, Centers for Disease Control Elimination of Mother-to-Child HIV Transmission in the United States

RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS:
Active
Peer Review
Title:
Ryan White CARE Act Part D grant to support the WI HIV Primary Care Support Network
Dates:
2007 - 2012
Direct Funds:
$847,712 (yearly for 5 years. Medical director – 1.1% funded effort)
 
Prior
Peer Review
Title:
Dr. Elaine Kohler Fund for Humanity in Medicine
Source:
Children's Hospital of Wisconsin Foundation
Dates:
1991
Direct Funds:
$250,000 (Pediatric Critical Care Medicine)
 
Title:
SHARE WITH KIDS Program: Needs assessment for Pediatric/Adolescent HIV care program in Milwaukee, WI
Source:
Hemophilia-Pediatric AIDS Special Initiative, Maternal and Child Health Program Grant Number MCH-55HP52-01-0.
PI:
Janice Hand, Program Director; Kathleen Marquardt, Project coordinator; Dr Havens, Medical Director
Dates:
1992 - 1995
Direct Funds:
$219,000
 
Title:
Pediatric AIDS Foundation
Source:
to support the Pediatric HIV Care Program at Children's Hospital of Wisconsin
Dates:
1992
Direct Funds:
$6,000
 
Title:
research in Pediatric Critical Care Medicine at the Children's Hospital of Wisconsin Foundation
Source:
Steigleider Trust
Dates:
1992
Direct Funds:
$125,000
 
Title:
Pediatric HIV Care Program funding, program for Children with Special Health Care Needs
Dates:
1992
Direct Funds:
$28,000
 
Title:
Primary CARRE Project: Maternal and Child Health Bureau Pediatric/Adolescent HIV/AIDS Demonstration Project Grant for statewide program
Source:
enhance the care of HIV-infected patients in primary care settings throughout Wisconsin
Dates:
1993
Direct Funds:
$125,000
 
Title:
Pediatric HIV Care Program at Children's Hospital of Wisconsin
Source:
Stackner Family Foundation
Dates:
1993 - 1997
Direct Funds:
$4,000 (yearly for 5 years )
 
Title:
Maternal and Child Health Bureau Pediatric/Adolescent HIV/AIDS Demonstration Project Grant for statewide program to enhance the care of HIV-infected patients in primary care settings throughout WI
Source:
Wisconsin HIV Primary Care Support Network for Children, Adolescents, and Families
PI:
Dr. Havens
Dates:
1994
Direct Funds:
$125,000
 
Title:
Pediatric HIV Care Program at Children's Hospital of Wisconsin
Source:
Pelz family endowment
Dates:
1994
Direct Funds:
$25,000
 
Title:
Family Satisfaction Project
Source:
measure the perception of care delivery by families enrolled in the HIV Primary Care Support Network
Role:
Co-principal investigator
Dates:
1995 - 1996
Direct Funds:
$10,850
 
Title:
Wisconsin HIV Primary Care Support Network
Source:
Maternal and Child Health Bureau Pediatric/Adolescent HIV/AIDS Demonstration Project Grant for statewide program to enhance the care of HIV-infected patients in primary care settings throughout WI
PI:
Dr. Havens
Dates:
1995 - 1998
Direct Funds:
$250,000
 
Title:
State of Wisconsin HIV/AIDS Program contract to perform statewide teaching/training concerning recommendations for universal counseling and HIV testing for pregnant women in the state of Wisconsin
Dates:
1995 - 1996
Direct Funds:
$45,000
 
Title:
Primary Prevention of Developmental Disabilities Grant to educate providers and consumers about prevention of HIV infection in children
Dates:
1995 - Present
Direct Funds:
$5,000
 
Title:
Bureau of Health Professions General Internal Medicine/General Pediatrics Faculty Development Grant
Source:
Epidemiology and Clinical Research to faculty in Internal Medicine and Pediatrics
PI:
Dr. Havens
Dates:
1996 - 1999
Direct Funds:
$4,000
 
Title:
State of Wisconsin/Centers for Disease Control and Prevention Enhanced HIV/AIDS Surveillance Project for Pregnant Women and Children
Role:
Principal Investigator
PI:
Self
Dates:
1997 - 1998
Direct Funds:
$135,000
 
Title:
Ryan White CARE Act Title IV grant to support the WI HIV Primary Care Support Network
Dates:
1998 - 2001
Direct Funds:
$405,443 (yearly for 3 years. Medical director)
 
Title:
Ryan White CARE Act Title IV supplemental grant to support the WI HIV Primary Care Support Network
Dates:
1999 - 2001
Direct Funds:
$75,000
 
Title:
African American Children's Initiative grant to support the WI HIV Primary Care Support Network
Dates:
1999 - 2001
Direct Funds:
$95,000
 
Title:
Ryan White CARE Act Title II Grant to support the WI HIV Primary Care Support Network
Dates:
2000 - 2001
Direct Funds:
$109,603
 
Title:
Ryan White CARE Act Title IV grant to support the WI HIV Primary Care Support Network
Dates:
2001 - 2003
Direct Funds:
$663,873 (Second year $746,436. Third year $856,276. Medical director - 10% funded effort)
 
Title:
Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network
Dates:
2001 - 2003
Direct Funds:
$109,603
 
Title:
Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention
Source:
NIH grant number: U01 HD40533-02
Dates:
2002 - 2003
Direct Funds:
$32,976
 
Title:
Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network
Dates:
2003 - 2004
Direct Funds:
$86,080 (Medical director - 2.16% funded effort)
 
Title:
2004-2005 Pediatric AIDS Clinical Trials Group. Affiliate of the Children’s Memorial Hospital (Chicago) PACTU
Source:
NIH grant number U01-AI041089 - 3% funded effort, 8% unfunded effort
Dates:
2004 - 2005
 
Title:
Ryan White CARE Act Title IV grant to support the WI HIV Primary Care Support Network
Dates:
2004 - 2007
Direct Funds:
$856,276 (Medical director - 10% funded effort)
 
Title:
Protocol Chair, Adolescent Trials Network study 056
Source:
Pharmacokinetics of once daily antiretroviral therapy regimens containing tenofovir and atazanavir/ritonavir in adolescents and young adults with HIV infection
Dates:
2005 - 2007
 
Title:
Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine
Source:
Trials Network for HIV/AIDS Intervention. NIH grant number U01 HD40533-05
Dates:
2005 - 2006
Direct Funds:
$21,325 (5% funded effort)
 
Title:
Pediatric AIDS Clinical Trials Group. Affiliate of the Children’s Memorial Hospital (Chicago) PACTU
Source:
NIH grant number U01-AI041089
Dates:
2005 - 2006
Direct Funds:
$11,250 (2.87% funded effort)
 
Title:
Preventing Perinatal HIV Transmission-Wisconsin Provider Education Series
Source:
of Dimes-Wisconsin Chapter Community Award
Dates:
2005 - 2006
Direct Funds:
$16,663
 
Title:
Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network
Dates:
2005 - 2006
Direct Funds:
$89,402 (Medical director – 1.38% funded effort)
 
Title:
2005 Pediatric HIV Treaters’ Data Collection Presentation Template
Source:
Midwest AIDS Training & Education Center, University of Illinois at Chicago grant number 5 H4AHA00062-03
Dates:
2005
Direct Funds:
$6,260
 
Title:
Ryan White CARE Act Title II grant to support the WI HIV Primary Care Support Network
Dates:
2006 - 2007
Direct Funds:
$150,600 (Medical director – 5% funded effort)
 
Title:
Therapeutic Leadership Group of the Adolescent Medicine Leadership Group of the Adolescent Medicine Trials Network for HIV/AIDS Intervention (ATN)
Source:
NIH grant number U01 HD40533-05
Dates:
2006 - 2010
Direct Funds:
$63,358 (20% funded effort)
 
Title:
Ryan White CARE Act Part D expansion grant to support revisions to data system of the WI HIV Primary Care Support Network
Dates:
2007 - 2008
Direct Funds:
$74,981 (Medical director – 2.8% funded effort)
 
Title:
Protocol Chair, Adolescent Trials Network study 063
Dates:
2007 - Present
 
Title:
Ryan White CARE Act Part B grant to support the WI HIV Primary Care Support Network
Dates:
2007 - 2010
Direct Funds:
$210,600 (Medical director – 4.5% funded effort)
 
Title:
Ryan White CARE Act Part D expansion grant to support electronic connections of outside laboratory data to the revised data system of the WI HIV Primary Care Support Network
Dates:
2008 - 2009
Direct Funds:
$74,981 (Medical director – 2.8% funded effort)
 

INVITED LECTURES/WORKSHOPS/PRESENTATIONS:
National
Invited Lecturer and Consultant, CDC Smallpox Preparedness and Response Training, 2001 - 2003
 
International
Lecturer, Centers for Disease Control (CDC) Training conference in Pediatric and Perinatal HIV, St. Petersburg, Russia, 03/18/2007 - 03/23/2007
Consultant and lecturer, Center for International Health Pediatric HIV Pharmacy Training Program, Lusaka and Livingstone, Zambia, 2007 - 2010
 

COMMITTEE SERVICE:
Hospital
1987 - 2006 Member, Infection Control Committee
1987 - 1992 Member, Drug Usage Review Committee
1987 - 1988 Member, Utilization and Quality Review Committee
1989 - 2001 Member, Pharmacy and Therapeutics Committee
1990 - 1996 Member, Medical Records Steering Committee
1990 - 1995 Member, Nutritional Support Committee
1990 - 1991 Member, Laboratory Advisory Committee
1992 Member, Central Venous Line Complication Task Force
1992 - 1993 Chair, Central Venous Line Complication Committee
1994 - 1996 Co-Chair, Central Venous Line Quality Improvement Task Force
2006 - Present Member, Data Safety Monitoring Board, Children’s Hospital of Wisconsin
2010 Member, Children’s Research Institute Clinical Effectiveness Research Task Force
 

MEDICAL COLLEGE TEACHING ACTIVITIES:
Community/Lay Public
2002 - Present “HIV Treaters Conference”. Organized for practitioners caring for persons with HIV infection throughout southeastern WI: a monthly meeting to present cases and discuss issues in HIV treatment.
2004 - Present “Pediatric HIV Treaters Conference”. Organized with Dr. Laura Hoyt (Minneapolis) and MATEC-Minnesota.
 
Medical Student Education
1988 Medical Microbiology Conference Group Leader
1989 - 1993 Freshman Biostatistics Course (M1): Lecture on Infectious Diseases Epidemiology
1996 General Pathology Course (Pathology 200) lecture on Infectious Diseases Epidemiology.
 
Resident and Fellow Education
1987 - 1989 PL-3 Teaching Conferences, monthly
1987 - 2001 Daily lectures to residents when on call in PICU (to 1995) or Intermediate ICU (1996-2001).
1990 - Present Research Methods Workshop Co-Director. Initially a course for Clinical Fellows and Medical College Faculty, has also been for Graduate Credit in Epidemiology since 1995.
1994 - Present Weekly attendance at PL-3 "Senior Rounds" teaching conference
1995 - 2000 PL-3 Journal Club adviser
1996 - 1999 Faculty Development Program, Lecture series on Conducting Clinical Research, to Faculty in Pediatrics, Family and Community Medicine, and General Internal Medicine
1998 - Present Academic Fellowship in Primary Care Research (National Research Service Award): Program steering committee and research faculty
2001 - 2006 Once or twice monthly lectures on infectious diseases topic to residents and medical students on Intermediate ICU rotation
2005 - Present Designing Clinical Research: A Short Course. Series of 6 lecture and discussion sessions for faculty in Pediatric Critical Medicine and Pediatric Emergency Medicine
2005 - Present Scholarship oversight committees for fellows in Critical Care, Neonatology, Cardiology, Emergency Medicine
 
Graduate Student Education
1987 - 1993 WisconsinDepartment of Biostatistics and Clinical Epidemiology (Biostatistics 200), Active participant in weekly seminar for graduate students
1993 Advanced Topics in Epidemiology (Biostatistics 202): Series on Infectious Diseases Epidemiology for Biostatistics/ Clinical Epidemiology Graduate course.
1995 - Present Research Methods Workshop
1995 - 1998 Active participant in weekly seminar for graduate students in the Health Policy Institute graduate program in Epidemiology
1995 Infectious Diseases Epidemiology Graduate Seminar (Epi 270: 1 credit). Graduate Program in Epidemiology
 

MCW STUDENTS, FACULTY, RESIDENTS AND CLINICAL/RESEARCH FELLOWS MENTORED:
Graduate Students
MS Committees
Ramesh Sachdeva, Medical College of Wisconsin, 1992 - 1993 Graduate School advisor/ thesis Committee Master of Science degree in Biostatistics/Clinical Epidemiology
Alan Burkowsky, Medical College of Wisconsin, 1994 - 1996 candidate for Master of Science degree in Epidemiology
Kay Sichting, Medical College of Wisconsin, 1995 - 1997 candidate for Master of Science degree in Epidemiology
Cheryl Flynn, M.D., Medical College of Wisconsin, 1997 Master of Science degree in Epidemiology
Raj Nijhawan, M.D, Medical College of Wisconsin, 1999 candidate for Master of Science degree in Epidemiology
Kelly Skoumal (Tieves), M.D.,, Medical College of Wisconsin, 2000 - 2003 candidate for Master of Science degree in Epidemiology
Yolanda Rainge, M.D, Medical College of Wisconsin, 2000 candidate for Master of Science degree in Epidemiology
Noah Leigh, Medical College of Wisconsin, 2005 - 2006 candidate for Master of Science degree in Epidemiology
Rupali Fuldeore, Medical College of Wisconsin, 2007 - 2008 Master of Science degree in Epidemiology
PhD Committees
Matthew Scanlon, M.D., Medical College of Wisconsin, 1997 - 1999 candidate for Master of Science degree in Epidemiology
 

COMMUNITY SERVICE ACTIVITIES:
1987 - 1993 Physician Consultant to the Shorewood Health Board
1990 - 1992 Shorewood Kickers Soccer Coach (under 6)
1990 Member, Milwaukee Metropolitan AIDS Planning Project, Provider Concerns Task Force
1991 - 1997 Steering Committee of the AIDS Coalition of Milwaukee
1991 - 1999 Milwaukee HIV Services Consortium
1991 - 2004 City of Milwaukee Pediatric HIV Coordinating Committee
1995 - 1998 Nicolet Kickers Soccer Coach
 


BIBLIOGRAPHY
Refereed Journal Publications/Original Papers
1. Havens PL. Comparative zone electrophoresis and mating experiments in the taxonomy of Mucor hiemalis. Mycotaxon 1976; 4:218-232.
2. Christie CDC, Havens PL, Shapiro ED. Bacteremia with group A Streptococci in childhood. AJDC 1988; 142:559-561.
3. Leung DY, Moake JL, Havens PL, Kim M, Pober JS. Lytic anti-endothelial cell antibodies in haemolytic uraemic syndrome. Lancet ii 1988; 183-186.
4. Havens PL, O'Rourke PP, Hahn J, Higgins J, and Walker AM. Laboratory and clinical variables to predict outcome in hemolytic uremic syndrome. AJDC 1988; 142:961-964.
5. Havens PL, Splaingard ML, Bousounis D, Hoffman GM. Survival after chloroquine ingestion in a child. J Toxicol-Clin Toxicol 1988; 26:381-388.
6. Hahn JS, Havens PL, Higgins JJ, O'Rourke PP, Estroff JA, Strand R. Neurological complications in hemolytic uremic syndrome. J Child Neurol 1989;4:108-113.
7. Splaingard ML, Gaebler D, Havens PL, Kalichman M. Outcome in children with severe brain injury requiring both tracheostomies and gastrostomies. Arch Phys Med Rehabil 1989;70:318-321.
8. Havens PL, Sty JR, Wells RG. Gallium-67 Imaging: chloroquine overdose. Clinical Nuclear Medicine l989;14:135.
9. Havens PL, Hoffman GM, Sheth KJ. The homogeneous nature of the hemolytic uremic syndrome. Clin Pediatrics 1989;28:482-483.
10. Havens PL, Garland JS, Brook MS, Dewitz BA, Stremski ES, Troshynski TJ. Trends in mortality in children hospitalized with meningococcal infections, l957-1987. Pediatr Infect Dis J 1989; 8:8-11.
11. Havens PL, Wendelberger KJ, Hoffman GM, Lee MB, Chusid MJ. Corticosteroids as adjunctive therapy in bacterial meningitis: A meta-analysis of clinical trials. AJDC 1989;143:1051-1055.
12. Losek JD, Dewitz-Zink BA, Melzer-Lange M, and Havens PL. Epiglottitis: Comparison of signs and symptoms in children less than two years and older children. Ann Emerg Med 1990;19:55-58.
13. Rutledge SL, Havens PL, Haymond MW, McLean RH, Kan JS, Brusilow SW. Neonatal Hemodialysis: Effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr 1990;116:125-128.
14. Casper JT, Ash RA, Kirchner P, Hunter JB, Havens PL, Chusid MJ. Successful treatment of an HLA-deficient SCIDS patient ("Bare lymphocyte syndrome") with an unrelated bone marrow transplant. J Pediatr 1990;116:262-265.
15. Garland JS, Rice TB, Wendelberger KJ, Havens PL: Presentation and course of Group A Streptococcal supraglottitis. Wis Med J 1991;90:55-57.
16. Torres A, Krilov LR, Jacobsen JM, Kelly KJ, and Havens PL. Reduced environmental exposure to aerosolized ribavirin using a simple scavenging system. Pediatr Infect Dis J 1991;10:217-21.
17. *Garland JS, Dunne WM, Havens PL, Hintermeyer M, Bozette MA, Wincek J, Bamberger T, Seavers M. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics 1992;89:1145-50.
18. Havens PL, Dunne WM, and Burd EM. Effects of human intravenous immune globulin on diarrhea caused by shiga-like toxins I and II in infant rabbits. Microbiol and Immunol 1992;36:1077-1085.
19. Havens PL, Butler J, Day SE, Mohr BA, Davis JP, and Chusid MJ. Treating measles: The appropriateness of admission to a Wisconsin children's hospital. Am J Pub Health 1993;83:379-384.
20. Butler JC, Havens PL, Sowell AL, Huff DL, Peterson DE, Day SE, Chusid MJ, Bennin RA, Circo R, Davis JP. Measles severity and serum retinol (vitamin A) concentration among children in the United States. Pediatrics 1993;91:1176-1181.
21. Chusid MJ, Havens PL, Coleman CN. Alpha Omega Alpha election and medical school thesis publication: Relationship to subsequent publication rates over 20 year period. Yale J Biol Med 1993;66:67-73.
22. Gedeit RG, Weigle CGM, Havens PL, and Werlin SL. Control and variability of gastric pH in critically ill children. Crit Care Med 1993;21:1850-55.
23. Kelly KJ Pearson ML, Kurup VP, Havens PL, Byrd RS, Setlock MA, Butler JC, Slater JE, Grammer LC, Resnick A, Roberts M, Jarvis WR, Davis JP, Fink JN. A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: Epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol 1994;94:53-61
24. Dunne WM, Tillman J, Havens PL. Assessing the need for anaerobic medium for the recovery of clinically significant blood culture isolates in children. Pediatric Infectious Diseases Journal 1994;13:203-6.
25. Sheth KJ, Gill JC, Leichter HE, Havens PL, Hunter JB. Increased incidence of HLA-B40 group antigens in children with hemolytic-uremic syndrome. Nephron 1994;68:433-436.
26. Madagame ET, Havens PL, Bresnahan JM, Babel KL, Splaingard ML. Survival and functional outcome of children requiring mechanical ventilation during therapy for acute bacterial meningitis. Critical Care Medicine 1995;23:1279-1283.
27. Kehl KSC, Cicirello H, Havens PL. Comparison of four different methods for the detection of Cryptosporidium species. J Clin Microbiol 1995;33:416-418.
28. Timmons OT, Havens PL, Fackler J, and the Pediatric Critical Care Study Group. Predicting death in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Extracorporeal Life Support Organization. Chest 1995;108:789-97.
29. Chusid MJ, Splaingard ML, Tweddell JS, Rice TB, Adams M, Havens PL, Kehl KS. Pulmonary tuberculosis following lung-liver transplantation for cystic fibrosis. Pediatric Infectious Diseases Journal 1996;15:462-464.
30. Yabut B, Werlin SL, Havens P, Bohorfoush A, Brown CW, Harb J. Endoscopic retrograde cholangiopancreatography in children with HIV infection. J Pediatr Gastroent Nutr 1996;23:624-627.
31. Garland J, Alex C, Gleisberg D, Havens P. Clinical utility of a glucose reflectance meter for screening neonates for hypoglycemia. J Perinatology 1996;16:250-3 (quiz:254-255).
32. Havens PL, Cuene BE, Hand J, Waters D, Chusid MJ. Structure of a primary care support system to coordinate comprehensive care for children and families infected/affected by HIV in a managed care environment. Ped Infect Dis J 1997;16:211-216.
33. Havens PL, Cuene BE, Holtgrave DR. Lifetime cost of care for children with HIV infection. Ped Infect Dis J 1997;16:607-10.
34. Havens PL, Cuene BE, Hand JR, Gern JE, Sullivan BW, Chusid MJ. Effectiveness of intensive nurse case management in decreasing vertical transmission of Human Immunodeficiency Virus infection in Wisconsin. Ped Infect Dis J 1997;16:871-5.
35. *Spack L, Havens PL, Griffith OW. Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome. Crit Care Med 1997;25:1071-8.
36. Spack L, Gedeit R, Splaingard M, Havens P. Failure of aggressive therapy to alter outcome in pediatric near drowning. Ped Emergency Care 1997;13:98-102.
37. Thakker JC, Splaingard M, Zhu J, Babel J, Bresnahan J, Havens PL. Survival and functional outcome of children requiring endotracheal intubation during therapy for severe traumatic brain injury. Crit Care Med 1997;25:1396-1401.
38. Cicirello HG, Kehl KS, Addiss DG, Chusid MJ, Glass RI, Davis JP, Havens PL. Cryptosporidiosis in children during a massive waterborne outbreak, Milwaukee, Wisconsin: Clinical, Laboratory, and epidemiologic findings. Epidemiol Infect 1997;119:53-60.
39. Kehl, KS, Havens P, Behnke CE, Acheson DW. Evaluation of the Premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol 1997;35:2051-4.
40. Havens PL. Acute otitis media in children: What next when first-line therapy fails? Consultant 1998;38:2681-2684, 2687-2690.
41. Balasubramanyan N, Havens PL, Hoffman GM. Unmeasured anions identified by the Fencl-Stewart method predict mortality better than base excess, anion gap, and lactate in patients in the pediatric intensive care unit. Crit Care Med 1999;27:1577-81.
42. Kehl SC, Havens PL, Chusid MJ. Prevalence of penicillin-resistant and multi-drug resistant Streptococcus pneumoniae at a children's hospital. Wi Med J 1999;98:42-5.
43. Beckmann KR, Melzer-Lange MD, Cuene B, Dietz M, Havens PL. The effectiveness of a followup program at improving human immunodeficiency virus testing in a pediatric emergency department. Wi Med J 2002;101:30-34.
44. Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology 2003;228:370 378.
45. Ramirez S, Hild TG, Rudolph CN, Sty JR, Kehl SC, Havens P, Henrickson K, Chusid MJ. Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a children's hospital. Pediatrics. 2003;112:e380-e385.
46. Rao AR, Splaingard MS, Gershan WM, Havens PL, Thill A, Barbieri JT. Detection of Pseudomonas aeruginosa type-III antibodies in children with tracheostomies. Pediatric Pulmonology 2005;39:402-407.
47. Franklin S, Lim HJ, Rennie KM, Eastwood D, Cuene B, Havens PL. Longitudinal Intellectual assessment of children with HIV infection. Journal of Clinical Psychology in Medical Settings 2005;12:367-76.
48. Skelton JA, Havens PL, Werlin SL. Nutrient deficiencies in tube fed children. Clin Pediatr 2006;45:37-41
49. Skelton JA, Busey SL, Havens PL. Weight and Health Status of Inner City African American Children: Perceptions of Children and their Parents. Body Image 2006;3:289-293
50. Lee KJ, Havens PL, Sato TT, Hoffman GM, Leuthner SR. Assent for treatment: clinician knowledge, attitudes, and practice. Pediatrics 2006;118:723-730
51. Destino L, Sutton DA, Helon AL, Havens PL, Thometz JG, Willoughby RE, Chusid MJ. Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury. Ann Clin Micro Antimicrob 2006; 5:21.
52. Hanson SJ, Punzalan RC, Ghanayem N, Havens PL. Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass, Pediatric Crit Care Med 2007;8:358-61
53. Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, Havens P, Purswami M, Guar AH, Chadwick EG, and the Pediatric AIDS Clinical Trials Group P1030 Team. Early archiving and predominance of non-nucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis 2007;195:1402-10.
54. Gordon JB, Colby HH, Bartelt T, Jablonski D, Krauthoefer ML, Havens P. A tertiary care-primary care partnership model for medically complex and fragile children and youth with special health care needs. Arch Pediatr Adolesc Med 2007;161:937-944.
55. Franklin JA, Lim HJ, Havens PL. Longitudinal academic and social progress of children with perinatally acquired HIV. Journal of Clinical Psychology in Medical Settings, 2007;14:335-343.
56. Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani, RM, Liu NX, Muenz LR, Harris DR, Havens PL, and the Adolescent Trials Network for HIV/AIDS Interventions. Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir/ritonavir in adolescents and young adults with HIV infection - study ATN056. Antimicrob Agents Chemother, 2008;52:631-37
57. Petroll A, Galletly C, Havens PL, Kwiecinski MF, Pinkerton S. Updated CDC guidelines for HIV testing: A review for Wisconsin Practitioners. Wisconsin Med J 2008;107:84-90
58. Robbins BL, Capparelli EV,, Chadwick EG, Yogev R, Serchuck L, Worrell C, Smith ME, Alvero C, Fenton T, Heckman B, Pelton SI, Aldrovandi G, Borkowsky W, Rodman J, and Havens PL, for the PACTG 1038 Team. Pharmacokinetics of High-Dose Lopinavir/Ritonavir with and without Saquinavir or Non-Nucleoside Reverse Transcriptase Inhibitors in HIV Infected Pediatric and Adolescent Patients Previously Treated with Protease Inhibitors - Study PACTG P1038. Antimicrobial Agents Chemother 2008;52:3276-3283.
59. Hanson SJ, Kim M, Berens R, Hoffman GM, Havens PL. Effect of Volume Resuscitation on Regional Perfusion in Dehydrated Pediatric Patients as Measured by Two-site Near-infrared Spectroscopy. Pediatric Emergency Care 2009;25:150-153.
60. Kumar S, Chusid MJ, Willoughby RE, Havens PL, Kehl SC, Ledeboer NA, Li SH, Henrickson KJ. Introduction of a novel swine-origin influenza A (H1N1) virus into Milwaukee, Wisconsin in 2009. Viruses 2009;1:72-83.
61. Mitchell ME, McManus M, Dietz J, Camitta, BM, Szabo S, Havens PL. Absidia corymbifera endocarditis: Survival after treatment of disseminated mucormycosis with radical resection of tricuspid valve and right ventricular free wall. J Thorac CV Surg 2010;139:e71-2
62. Hanson SJ, Punzalan R, Sato, T, Greenup R, Liu H, Havens PL. Incidence and risk factors for venous thromboembolism in critically ill children after trauma. J Trauma, 2010;68:52-6.
63. Gupta S, Havens PL, Southern JF, Firat SY, Jogal SS. Epstein-Barr virus associated intracranial leiomyosarcoma in an HIV positive adolescent. J Pediatr Hematol Oncol 2010 Mar 10 (epub).
64. Kumar S, Chusid MJ. Willoughby RE, Havens PL, Kehl SC, Ledeboer NA, Simpson P, Vandyke M, Davis E, Gaffney L, Li SH, Bose ME, Henrickson KJ. Epidemiologic observations from passive and targeted surveillance during the first wave of the 2009 H1N1 influenza pandemic in Milwaukee, WI. Viruses 2010:2(4):782-795
65. Kumar S, Havens PL, Chusid MJ, Willoughby RE Jr, Simpson P, Henrickson KJ. Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J 2010(7): 591-4
66. Gupta S, Cogbill CH, Gheorghe G, Rao AR, Kumar S, Havens PL, Camitta BM, Warwick AB. Mycobacterium avium intracellulare Infection Coexistent With Nodular Lymphocyte Predominant Hodgkin Lymphoma Involving the Lung. J Pediatr Hematol Oncol 2011 Mar 10 (epub)
67. Losek JD, Dewitz-Zink BA, Melzer-Lange M, Havens PL. Epiglottitis: comparison of signs and symptoms in children less than 2 years old and older. Ann Emerg Med. 1990 Jan;19(1):55-8.
68. Rutledge SL, Havens PL, Haymond MW, McLean RH, Kan JS, Brusilow SW. Neonatal hemodialysis: effective therapy for the encephalopathy of inborn errors of metabolism. J Pediatr. 1990 Jan;116(1):125-8.
69. Havens PL. Meta-analysis redux-steroids and meningitis revisited. West J Med. 1992 Jul;157(1):84-6. PMCID: PMC1021923
70. Havens PL, Sty JR, Wells RG. Gallium-67 imaging: chloroquine overdose. Clin Nucl Med. 1989 Feb;14(2):135.
71. Havens PL, Wendelberger KJ, Hoffman GM, Lee MB, Chusid MJ. Corticosteroids as adjunctive therapy in bacterial meningitis. A meta-analysis of clinical trials. Am J Dis Child. 1989 Sep;143(9):1051-5.
72. Havens PL, Garland JS, Brook MM, Dewitz BA, Stremski ES, Troshynski TJ. Trends in mortality in children hospitalized with meningococcal infections, 1957 to 1987. Pediatr Infect Dis J. 1989 Jan;8(1):8-11.
73. Torres A Jr, Krilov LR, Jacobson JM, Kelly KJ, Havens PL. Reduced environmental exposure to aerosolized ribavirin using a simple containment system. Pediatr Infect Dis J. 1991 Mar;10(3):217-21.
74. Christie CD, Havens PL, Shapiro ED. Bacteremia with group A streptococci in childhood. Am J Dis Child. 1988 May;142(5):559-61.
75. Kehl KS, Cicirello H, Havens PL. Comparison of four different methods for detection of Cryptosporidium species. J Clin Microbiol. 1995 Feb;33(2):416-8. PMCID: PMC227959
76. Timmons OD, Havens PL, Fackler JC. Predicting death in pediatric patients with acute respiratory failure. Pediatric Critical Care Study Group. Extracorporeal Life Support Organization. Chest. 1995 Sep;108(3):789-97.
77. Sheth KJ, Gill JC, Leichter HE, Havens PL, Hunter JB. Increased incidence of HLA-B40 group antigens in children with hemolytic-uremic syndrome. Nephron. 1994;68(4):433-6.
78. Butler JC, Havens PL, Sowell AL, Huff DL, Peterson DE, Day SE, Chusid MJ, Bennin RA, Circo R, Davis JP. Measles severity and serum retinol (vitamin A) concentration among children in the United States. Pediatrics. 1993 Jun;91(6):1176-81.
79. Havens PL, Butler JC, Day SE, Mohr BA, Davis JP, Chusid MJ. Treating measles: the appropriateness of admission to a Wisconsin children's hospital. Am J Public Health. 1993 Mar;83(3):379-84. PMCID: PMC1694644
80. Dunne WM Jr, Tillman J, Havens PL. Assessing the need for anaerobic medium for the recovery of clinically significant blood culture isolates in children. Pediatr Infect Dis J. 1994 Mar;13(3):203-6.
81. Chusid MJ, Splaingard ML, Tweddell JS, Rice TR, Adams M, Havens PL, Kehl KS. Pulmonary tuberculosis after lung-liver transplantation from cystic fibrosis. Pediatr Infect Dis J. 1996 May;15(5):462-4.
82. Havens PL, Cuene BE, Waters D, Hand J, Chusid MJ. Structure of a primary care support system to coordinate comprehensive care for children and families infected/affected by human immunodeficiency virus in a managed care environment. Pediatr Infect Dis J. 1997 Feb;16(2):211-6.
83. Havens PL, Cuene BE, Holtgrave DR. Lifetime cost of care for children with human immunodeficiency virus infection. Pediatr Infect Dis J. 1997 Jun;16(6):607-10.
84. Kehl KS, Havens P, Behnke CE, Acheson DW. Evaluation of the premier EHEC assay for detection of Shiga toxin-producing Escherichia coli. J Clin Microbiol. 1997 Aug;35(8):2051-4. PMCID: PMC229901
85. Thakker JC, Splaingard M, Zhu J, Babel K, Bresnahan J, Havens PL. Survival and functional outcome of children requiring endotracheal intubation during therapy for severe traumatic brain injury. Crit Care Med. 1997 Aug;25(8):1396-401.
86. Beckmann KR, Melzer-Lange MD, Cuene B, Dietz M, Havens PL. The effectiveness of a follow-up program at improving HIV testing in a pediatric emergency department. WMJ. 2002;101(8):30-4.
87. Wells RG, Havens PL. Intrapleural fibrinolysis for parapneumonic effusion and empyema in children. Radiology. 2003 Aug;228(2):370-8.
88. Havens PL. Principles of antiretroviral treatment of children and adolescents with human immunodeficiency virus infection. Semin Pediatr Infect Dis. 2003 Oct;14(4):269-85.
89. Rao AR, Splaingard MS, Gershan WM, Havens PL, Thill A, Barbieri JT. Detection of Pseudomonas aeruginosa type III antibodies in children with tracheostomies. Pediatr Pulmonol. 2005 May;39(5):402-7.
90. Skelton JA, Havens PL, Werlin SL. Nutrient deficiencies in tube-fed children. Clin Pediatr (Phila). 2006 Jan-Feb;45(1):37-41.
91. American Academy of Pediatrics Committee on Pediatric AIDS, Section on International Child Health, Havens PL, Gibb DM. Increasing antiretroviral drug access for children with HIV infection. Pediatrics. 2007 Apr;119(4):838-45.
92. Gordon JB, Colby HH, Bartelt T, Jablonski D, Krauthoefer ML, Havens P. A tertiary care-primary care partnership model for medically complex and fragile children and youth with special health care needs. Arch Pediatr Adolesc Med. 2007 Oct;161(10):937-44.
93. Skelton JA, Busey SL, Havens PL. Weight and health status of inner city African American children: Perceptions of children and their parents. Body Image. 2006 Sep;3(3):289-93.
94. Robbins BL, Capparelli EV, Chadwick EG, Yogev R, Serchuck L, Worrell C, Smith ME, Alvero C, Fenton T, Heckman B, Pelton SI, Aldrovandi G, Borkowsky W, Rodman J, Havens PL, PACTG 1038 Team. Pharmacokinetics of high-dose lopinavir-ritonavir with and without saquinavir or nonnucleoside reverse transcriptase inhibitors in human immunodeficiency virus-infected pediatric and adolescent patients previously treated with protease inhibitors. Antimicrob Agents Chemother. 2008 Sep;52(9):3276-83. PMCID: PMC2533475
95. Hanson SJ, Berens RJ, Havens PL, Kim MK, Hoffman GM. Effect of volume resuscitation on regional perfusion in dehydrated pediatric patients as measured by two-site near-infrared spectroscopy. Pediatr Emerg Care. 2009 Mar;25(3):150-3.
96. Gupta S, Cogbill CH, Gheorghe G, Rao AR, Kumar S, Havens PL, Camitta BM, Warwick AB. Mycobacterium avium intracellulare infection coexistent with nodular lymphocyte predominant Hodgkin lymphoma involving the lung. J Pediatr Hematol Oncol. 2011 Apr;33(3):e127-31.
97. Flynn P, Havens P, Brady M, Emmanuel P, Read J, Hoyt L, Henry-Reid L, Van Dyke R, Mofenson L. Male circumcision for prevention of HIV and other sexually transmitted diseases. Pediatrics. 2007 Apr;119(4):821-2.
98. Kumar S, Chusid MJ, Willoughby RE, Havens PL, Kehl SC, Ledeboer NA, Li SH, Henrickson KJ. Introduction of a Novel Swine-Origin Influenza A (H1N1) Virus into Milwaukee, Wisconsin in 2009. Viruses. 2009 06 01;1(1):72-83. PMCID: PMC2768288
99. Mofenson LM, Brady MT, Danner SP, Dominguez KL, Hazra R, Handelsman E, Havens P, Nesheim S, Read JS, Serchuck L, Van Dyke R, Centers for Disease Control and Prevention, National Institutes of Health, HIV Medicine Association of the Infectious Diseases Society of America, Pediatric Infectious Diseases Society, American Academy of Pediatrics. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep. 2009 Sep 04;58(RR-11):1-166. PMCID: PMC2821196
100. Gupta S, Havens PL, Southern JF, Firat SY, Jogal SS. Epstein-Barr virus-associated intracranial leiomyosarcoma in an HIV-positive adolescent. J Pediatr Hematol Oncol. 2010 May;32(4):e144-7.
101. Balasubramanyan N, Havens PL, Hoffman GM. Unmeasured anions identified by the Fencl-Stewart method predict mortality better than base excess, anion gap, and lactate in patients in the pediatric intensive care unit. Crit Care Med. 1999 Aug;27(8):1577-81.
102. Kumar S, Chusid MJ, Willoughby RE, Havens PL, Kehl SC, Ledeboer NA, Simpson P, Vandyke M, Davis E, Gaffney K, Li SH, Bose ME, Henrickson KJ. Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI. Viruses. 2010;2(4):782-795. PMCID: PMC2905828
103. Hanson SJ, Punzalan RC, Christensen MA, Ghanayem NS, Kuhn EM, Havens PL. Incidence and risk factors for venous thromboembolism in critically ill children with cardiac disease. Pediatr Cardiol. 2012 Jan;33(1):103-8.
104. Havens PL, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions 063 study team. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin Infect Dis. 2012 Apr;54(7):1013-25. PMCID: PMC3297650
105. Havens PL, Mulligan K, Hazra R, Flynn P, Rutledge B, Van Loan MD, Lujan-Zilbermann J, Kapogiannis BG, Wilson CM, Stephensen CB, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 Study Team. Serum 25-hydroxyvitamin D response to vitamin D3 supplementation 50,000 IU monthly in youth with HIV-1 infection. J Clin Endocrinol Metab. 2012 Nov;97(11):4004-13. PMCID: PMC3485594
106. Porter TR, Li X, Stephensen CB, Mulligan K, Rutledge B, Flynn PM, Lujan-Zilbermann J, Hazra R, Wilson CM, Havens PL, Tang J, Adolescent MedicineTrials Network for HIV/AIDS Interventions (ATN) 063 study team. Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein. Front Genet. 2013;4:234. PMCID: PMC3827582
107. Hanson SJ, Havens PL, Simpson PM, Nugent ML, Wells RG. Intrapleural alteplase decreases parapneumonic effusion volume in children more than saline irrigation. Pediatr Pulmonol. 2015 Dec;50(12):1328-35.
108. Zembles TN, Thompson NE, Havens PL, Kaufman BA, Huppler AR. An Optimized Voriconazole Dosing Strategy to Achieve Therapeutic Serum Concentrations in Children Younger than 2 Years Old. Pharmacotherapy. 2016 10;36(10):1102-1108.
109. Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Liu N, Wilson CM, Hazra R, Hosek SG, Anderson PL, Seifert SM, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions 117 study team. Decline in Bone Mass With Tenofovir Disoproxil Fumarate/Emtricitabine Is Associated With Hormonal Changes in the Absence of Renal Impairment When Used by HIV-Uninfected Adolescent Boys and Young Men for HIV Preexposure Prophylaxis. Clin Infect Dis. 2017 Feb 01;64(3):317-325. PMCID: PMC6366053
110. Casper JT, Ash RA, Kirchner P, Hunter JB, Havens PL, Chusid MJ. Successful treatment with an unrelated-donor bone marrow transplant in an HLA-deficient patient with severe combined immune deficiency ("bare lymphocyte syndrome"). J Pediatr. 1990 Feb;116(2):262-5.
111. Hahn JS, Havens PL, Higgins JJ, O'Rourke PP, Estroff JA, Strand R. Neurological complications of hemolytic-uremic syndrome. J Child Neurol. 1989 Apr;4(2):108-13.
112. Havens PL, Dunne WM, Burd EM. Effects of human intravenous immune globulin on diarrhea caused by Shiga-like toxin I and Shiga-like toxin II in infant rabbits. Microbiol Immunol. 1992;36(10):1077-85.
113. Havens PL, Hoffman GM, Shith KJ. The homogeneous nature of the hemolytic uremic syndrome. Clin Pediatr (Phila). 1989 Oct;28(10):482-3.
114. Leung DY, Moake JL, Havens PL, Kim M, Pober JS. Lytic anti-endothelial cell antibodies in haemolytic-uraemic syndrome. Lancet. 1988 Jul 23;2(8604):183-6.
115. Havens PL, Splaingard ML, Bousounis D, Hoffman GM. Survival after chloroquine ingestion in a child. J Toxicol Clin Toxicol. 1988;26(5-6):381-8.
116. Garland JS, Rice TB, Wendelberger KJ, Havens PL. Group A streptococcal supraglottitis: three case reports. Wis Med J. 1991 Feb;90(2):55-7.
117. Havens PL, O'Rourke PP, Hahn J, Higgins J, Walker AM. Laboratory and clinical variables to predict outcome in hemolytic-uremic syndrome. Am J Dis Child. 1988 Sep;142(9):961-4.
118. Madagame ET, Havens PL, Bresnahan JM, Babel KL, Splaingard ML. Survival and functional outcome of children requiring mechanical ventilation during therapy for acute bacterial meningitis. Crit Care Med. 1995 Jul;23(7):1279-83.
119. Sheth KJ, Gill JC, Havens PL, Leichter HE. Racial incidence of hemolytic-uremic syndrome. Pediatr Nephrol. 1995 Jun;9(3):401.
120. Gedeit RG, Weigle CG, Havens PL, Werlin SL. Control and variability of gastric pH in critically ill children. Crit Care Med. 1993 Dec;21(12):1850-5.
121. Kelly KJ, Pearson ML, Kurup VP, Havens PL, Byrd RS, Setlock MA, Butler JC, Slater JE, Grammer LC, Resnick A. A cluster of anaphylactic reactions in children with spina bifida during general anesthesia: epidemiologic features, risk factors, and latex hypersensitivity. J Allergy Clin Immunol. 1994 Jul;94(1):53-61.
122. Chusid MJ, Havens PL, Coleman CN. Alpha omega alpha election and medical school thesis publication: relationship to subsequent publication rate over a twenty-year period. Yale J Biol Med. 1993 Mar-Apr;66(2):67-73. PMCID: PMC2588837
123. Yabut B, Werlin SL, Havens P, Bohorfoush A, Brown CW, Harb J. Endoscopic retrograde cholangiopancreatography in children with HIV infection. J Pediatr Gastroenterol Nutr. 1996 Dec;23(5):624-7.
124. Kehl SC, Havens PL, Chusid MJ. Prevalence of penicillin resistant and multi-drug resistant Streptococcus pneumoniae at a children's hospital. WMJ. 1999 May-Jun;98(3):42-5.
125. Spack L, Gedeit R, Splaingard M, Havens PL. Failure of aggressive therapy to alter outcome in pediatric near-drowning. Pediatr Emerg Care. 1997 Apr;13(2):98-102.
126. Cicirello HG, Kehl KS, Addiss DG, Chusid MJ, Glass RI, Davis JP, Havens PL. Cryptosporidiosis in children during a massive waterborne outbreak in Milwaukee, Wisconsin: clinical, laboratory and epidemiologic findings. Epidemiol Infect. 1997 Aug;119(1):53-60. PMCID: PMC2808823
127. Havens PL, Cuene BE, Hand JR, Gern JE, Sullivan BW, Chusid MJ. Effectiveness of intensive nurse case management in decreasing vertical transmission of human immunodeficiency virus infection in Wisconsin. Pediatr Infect Dis J. 1997 Sep;16(9):871-5.
128. Banwart B, Splaingard ML, Farrell PM, Rock MJ, Havens PL, Moss J, Ehrmantraut ME, Frank DW, Barbieri JT. Children with cystic fibrosis produce an immune response against exoenzyme S, a type III cytotoxin of Pseudomonas aeruginosa. J Infect Dis. 2002 Jan 15;185(2):269-70.
129. Havens PL, American Academy of Pediatrics Committee on Pediatric AIDS. Postexposure prophylaxis in children and adolescents for nonoccupational exposure to human immunodeficiency virus. Pediatrics. 2003 Jun;111(6 Pt 1):1475-89.
130. Havens PL, Waters D. Management of the infant born to a mother with HIV infection. Pediatr Clin North Am. 2004 Aug;51(4):909-37, viii.
131. Lee KJ, Havens PL, Sato TT, Hoffman GM, Leuthner SR. Assent for treatment: clinician knowledge, attitudes, and practice. Pediatrics. 2006 Aug;118(2):723-30.
132. Destino L, Sutton DA, Helon AL, Havens PL, Thometz JG, Willoughby RE Jr, Chusid MJ. Severe osteomyelitis caused by Myceliophthora thermophila after a pitchfork injury. Ann Clin Microbiol Antimicrob. 2006 Sep 08;5:21. PMCID: PMC1592504
133. Hanson SJ, Punzalan RC, Ghanayem N, Havens P. Prevalence of heparin-dependent platelet antibodies in children after cardiopulmonary bypass. Pediatr Crit Care Med. 2007 Jul;8(4):358-61.
134. Kiser JJ, Fletcher CV, Flynn PM, Cunningham CK, Wilson CM, Kapogiannis BG, Major-Wilson H, Viani RM, Liu NX, Muenz LR, Harris DR, Havens PL, Adolescent Trials Network for HIV/AIDS Interventions. Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection. Antimicrob Agents Chemother. 2008 Feb;52(2):631-7. PMCID: PMC2224775
135. Ramirez S, Hild TG, Rudolph CN, Sty JR, Kehl SC, Havens P, Henrickson K, Chusid MJ. Increased diagnosis of Lemierre syndrome and other Fusobacterium necrophorum infections at a Children's Hospital. Pediatrics. 2003 Nov;112(5):e380.
136. Petroll AE, Galletly CL, Havens PL, Kwiecinski MF, Pinkerton SD. Updated CDC guidelines for HIV testing: a review for Wisconsin practitioners. WMJ. 2008 Apr;107(2):84-90. PMCID: PMC2536748
137. Havens PL, Mofenson LM, American Academy of Pediatrics Committee on Pediatric AIDS. Evaluation and management of the infant exposed to HIV-1 in the United States. Pediatrics. 2009 Jan;123(1):175-87.
138. Splaingard ML, Gaebler D, Havens P, Kalichman M. Brain injury: functional outcome in children with tracheostomies and gastrostomies. Arch Phys Med Rehabil. 1989 Apr;70(4):318-21.
139. Persaud D, Palumbo P, Ziemniak C, Chen J, Ray SC, Hughes M, Havens P, Purswani M, Gaur AH, Chadwick EG, Pediatric AIDS Clinical Trials Group P1030 Team. Early archiving and predominance of nonnucleoside reverse transcriptase inhibitor-resistant HIV-1 among recently infected infants born in the United States. J Infect Dis. 2007 May 15;195(10):1402-10.
140. Garland JS, Dunne WM Jr, Havens P, Hintermeyer M, Bozzette MA, Wincek J, Bromberger T, Seavers M. Peripheral intravenous catheter complications in critically ill children: a prospective study. Pediatrics. 1992 Jun;89(6 Pt 2):1145-50.
141. Hanson SJ, Punzalan RC, Greenup RA, Liu H, Sato TT, Havens PL. Incidence and risk factors for venous thromboembolism in critically ill children after trauma. J Trauma. 2010 Jan;68(1):52-6.
142. Kumar S, Fan J, Melzer-Lange M, Trost J, Havens PL, Willoughby RE, Chusid MJ, Henrickson KJ. H1N1 hemagglutinin-inhibition seroprevalence in Emergency Department Health Care workers after the first wave of the 2009 influenza pandemic. Pediatr Emerg Care. 2011 Sep;27(9):804-7.
143. Mitchell ME, McManus M, Dietz J, Camitta BM, Szabo S, Havens P. Absidia corymbifera endocarditis: survival after treatment of disseminated mucormycosis with radical resection of tricuspid valve and right ventricular free wall. J Thorac Cardiovasc Surg. 2010 Apr;139(4):e71-2.
144. Kumar S, Havens PL, Chusid MJ, Willoughby RE Jr, Simpson P, Henrickson KJ. Clinical and epidemiologic characteristics of children hospitalized with 2009 pandemic H1N1 influenza A infection. Pediatr Infect Dis J. 2010 Jul;29(7):591-4.
145. Hickey CA, Beattie TJ, Cowieson J, Miyashita Y, Strife CF, Frem JC, Peterson JM, Butani L, Jones DP, Havens PL, Patel HP, Wong CS, Andreoli SP, Rothbaum RJ, Beck AM, Tarr PI. Early volume expansion during diarrhea and relative nephroprotection during subsequent hemolytic uremic syndrome. Arch Pediatr Adolesc Med. 2011 Oct;165(10):884-9. PMCID: PMC4064458
146. Baheti G, Kiser JJ, Havens PL, Fletcher CV. Plasma and intracellular population pharmacokinetic analysis of tenofovir in HIV-1-infected patients. Antimicrob Agents Chemother. 2011 Nov;55(11):5294-9. PMCID: PMC3194996
147. Spack L, Havens PL, Griffith OW. Measurements of total plasma nitrite and nitrate in pediatric patients with the systemic inflammatory response syndrome. Crit Care Med. 1997 Jun;25(6):1071-8.
148. Hanson SJ, Punzalan RC, Arca MJ, Simpson P, Christensen MA, Hanson SK, Yan K, Braun K, Havens PL. Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. J Trauma Acute Care Surg. 2012 May;72(5):1292-7.
149. Chiu YE, Havens PL, Siegel DH, Ali O, Wang T, Holland KE, Galbraith SS, Lyon VB, Drolet BA. Serum 25-hydroxyvitamin D concentration does not correlate with atopic dermatitis severity. J Am Acad Dermatol. 2013 Jul;69(1):40-6. PMCID: PMC3661681
150. Havens PL, Kiser JJ, Stephensen CB, Hazra R, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 Study Team. Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency? Antimicrob Agents Chemother. 2013 Nov;57(11):5619-28. PMCID: PMC3811269
151. Havens PL, Hazra R, Stephensen CB, Kiser JJ, Flynn PM, Wilson CM, Rutledge B, Bethel J, Pan CG, Woodhouse LR, Van Loan MD, Liu N, Lujan-Zilbermann J, Baker A, Kapogiannis BG, Gordon CM, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 063 study team. Vitamin D3 supplementation increases fibroblast growth factor-23 in HIV-infected youths treated with tenofovir disoproxil fumarate. Antivir Ther. 2014;19(6):613-8. PMCID: PMC4135028
152. Schloemer NJ, Abu-Sultaneh S, Hanson SJ, Yan K, Hoffmann RG, Punzalan RC, Havens PL. Higher doses of low-molecular-weight heparin (enoxaparin) are needed to achieve target anti-Xa concentrations in critically ill children*. Pediatr Crit Care Med. 2014 Sep;15(7):e294-9.
153. Havens PL, Hazra R. Commentary: The place of tenofovir disoproxil fumarate in pediatric antiretroviral therapy. Pediatr Infect Dis J. 2015 Apr;34(4):406-8. PMCID: PMC4357556
154. Nguyen HS, Foy A, Havens P. Intracranial subdural empyema after surgery for lumbar lipomyelomeningocele: A rare complication. Surg Neurol Int. 2016;7(Suppl 12):S301-4. PMCID: PMC4879841
155. Balakrishnan B, Dasgupta M, Gajewski K, Hoffmann RG, Simpson PM, Havens PL, Hanson SJ. Low near infrared spectroscopic somatic oxygen saturation at admission is associated with need for lifesaving interventions among unplanned admissions to the pediatric intensive care unit. J Clin Monit Comput. 2018 Feb;32(1):89-96.
156. Havens PL, Stephensen CB, Van Loan MD, Schuster GU, Woodhouse LR, Flynn PM, Gordon CM, Pan CG, Rutledge B, Harris DR, Price G, Baker A, Meyer WA 3rd, Wilson CM, Hazra R, Kapogiannis BG, Mulligan K, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 109 Study Team. Vitamin D3 Supplementation Increases Spine Bone Mineral Density in Adolescents and Young Adults With Human Immunodeficiency Virus Infection Being Treated With Tenofovir Disoproxil Fumarate: A Randomized, Placebo-Controlled Trial. Clin Infect Dis. 2018 01 06;66(2):220-228. PMCID: PMC5848310
157. Yang J, Nikanjam M, Best BM, Pinto J, Chadwick EG, Daar ES, Havens PL, Rakhmanina N, Capparelli EV. Population Pharmacokinetics of Lopinavir/Ritonavir: Changes Across Formulations and Human Development From Infancy Through Adulthood. J Clin Pharmacol. 2018 12;58(12):1604-1617. PMCID: PMC6604805
158. Havens PL, Tamhane A, Stephensen CB, Schuster GU, Gordon CM, Liu N, Wilson CM, Hosek SG, Anderson PL, Kapogiannis BG, Mulligan K. Short Communication: Association of Vitamin D Insufficiency and Protective Tenofovir Diphosphate Concentrations with Bone Toxicity in Adolescent Boys and Young Men Using Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Pre-Exposure Prophylaxis. AIDS Res Hum Retroviruses. 2019 02;35(2):123-128. PMCID: PMC6360393
159. Havens PL, Long D, Schuster GU, Gordon CM, Price G, Wilson CM, Kapogiannis BG, Mulligan K, Stephensen CB, Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) 117 and 109 study teams. Tenofovir disoproxil fumarate appears to disrupt the relationship of vitamin D and parathyroid hormone. Antivir Ther. 2018;23(7):623-628.
160. Havens PL, Perumean-Chaney SE, Patki A, Cofield SS, Wilson CM, Liu N, Anderson PL, Landovitz RJ, Kapogiannis BG, Hosek SG, Mulligan K. Changes in Bone Mass After Discontinuation of Pre-Exposure Prophylaxis (PrEP) with Tenofovir Disoproxil Fumarate/Emtricitabine in Young Men Who Have Sex With Men: Extension Phase Results of Adolescent Trials Network Protocols 110 and 113. Clin Infect Dis. 2019 Jun 08.
161. Swartz S, Hadjiev J, Kolinski J, Chou E, Allen K, Yan K, Havens PL. Factors Associated With HSV PCR CSF Testing and Empiric Acyclovir Therapy in Young Febrile Infants. Clin Pediatr (Phila). 2019 Oct;58(11-12):1194-1200.
 
Books, Chapters, and Reviews
1. Havens PL. Nosocomial infections in the pediatric intensive care unit. Chapter 9, pp 101-111, in: Gioia FR and Yeh TS (eds). Pediatric Critical Care Clinical Review Series, Part 3. Society of Critical Care Medicine, 1991.
2. Havens PL. Nosocomial Pneumonia. in Kaplan SL (ed). Current Therapy in Pediatric Infectious Disease, Third edition. 1993. Mosby-Year Book, St. Louis, Mo.
3. Havens PL. Nosocomial infections in the pediatric intensive care unit. Chapter 9, pp 142-153, in: Stidham GL and Weigle CGM (eds). Pediatric Critical Care Clinical Review Series, Part 3. Society of Critical Care Medicine, 1994.
4. Havens PL. Evaluating medical literature: Clinical epidemiology. in Behrman RE and Kliegman RM (eds), Nelson Textbook of Pediatrics-15th edition. W.B. Saunders, 1996: 5-12.
5. Havens PL. Applying the medical literature to clinical decision making. in Kliegman RM, Nieder ML, and Super DM (eds), Practical Strategies in Pediatric Diagnosis and Therapy. W.B. Saunders, 1996: 15-24.
6. Havens PL and Davis JP. Cryptosporidium and cryptosporidiosis. Seminars Pediatr Infect Dis 1996;7:250-257.
7. Havens PL and Waters, DA. HIV Infection in Children. in Dershewitz RA (ed.), Ambulatory Pediatric Care, 3rd edition. Lippincott-Raven, Philadelphia. 1998.
8. Havens PL. Pediatric AIDS. in Armstrong D and Cohen J (eds), Infectious Diseases. Mosby, London. 1999.
9. Havens, PL. Diagnosis of HIV in Newborns. in Armstrong D and Cohen J (eds), Infectious Diseases. Mosby, London. 1999.
10. Havens PL. Meningismus and meningitis. In Kliegman RM, Greenbaum L, Lye P (eds), Practical Strategies in Pediatric Diagnosis and Therapy second edition . W.B. Saunders, 2002
11. Havens PL. Pediatric HIV. in Cohen J and Powderly WG (eds), Infectious Diseases, second edition. Mosby, London. 2003.
12. Havens, PL. Diagnosis of HIV in Newborns. in Cohen J and Powderly WG (eds), Infectious Diseases, second edition. Mosby, London. 2003.
13. Havens, PL. Principles of antiretroviral therapy for children with HIV infection. Seminars in Pediatr Infect Dis 2003;14:269-85
14. Havens PL and Waters D. Management of the infant born to a mother with HIV infection. Chapter for Pediatric Clinics of North America-Normal Newborns, 2004;51:909-937.
15. Havens PL and Dominguez K. HIV Postexposure Prophylaxis. Iin Zeichner S, and Read J. (eds) Handbook of Pediatric HIV Care, second edition. Cambridge University Press, 2006.
16. Waters D, Havens P, McClellan-Tilson B, Murphy D, Frisby H. Medical Management of Newborns and Infants Born to HIV-Infected Mothers. Wisconsin Department of Health and Social Services, Division of Health. Publication POH 4498 (Rev. 11/92).
17. Waters D, Havens P, McClellan-Tilson B, Murphy DA, Frisby HR, McIntosh, K. Medical Management of Newborns, Infants, and Children Born to HIV-Infected Mothers. Wisconsin Department of Health and Social Services, Division of Health. Publication POH 4498 (Rev. 10/93).
18. Havens, PL, Waters DA, Cuene BE, McIntosh K, Yogev R. Caring for Infants, Children, Adolescents, and Families with HIV Infection. Wisconsin Department of Health and Social Services, Division of Health. Publication POH 4498 (Rev. 12/95).
19. Havens, PL, Waters DA, Cuene BE, McIntosh K, Yogev R. Caring for Infants, Children, Adolescents, and Families with HIV Infection. Wisconsin Department of Health and Social Services, Division of Health. Publication POH 4498 (Rev. 12/96).
20. Havens, PL, Waters DA, Cuene BE, McIntosh K, Yogev R. Caring for Infants, Children, Adolescents, and Families with HIV Infection. Wisconsin Department of Health and Social Services, Division of Health. Publication POH 4498 (Rev. 3/98, revised 01/01at www.mcw.edu/peds/infectdis "HIV Care Guide).
 
Editorials, Letters to Editor, Other
1. Havens PL. Meta-analysis redux: steroids and meningitis revisited. West J Med 1992;157:84-86.
2. Havens PL. Combination therapy with efavirenz, nelfinavir, and nucleoside reverse-transcriptase inhibitors in children infected with HIV-1: Commentary. [JAMA HIV/AIDS Web site]. 2/29/2000. Available at: http://www.ama-assn.org.special/hiv/library/library.htm. Accessed 3/2/2000.
3. Flynn P, Havens P, Brady M, Emmanuel P, Read J, Hoyt L, Henry-Reid L, Van Dyke R, Mofenson L. Male Circumcision for prevention of HIV and other sexually transmitted diseases. (Commentary) Pediatrics 2007;119:821-822
4. Havens PL and Garland JS. Direct inspection of the epiglottis. AJDC 1988;142:1262.
5. Havens PL, Hoffman GM, Rice TB, Kelly KJ, Day SE, Wendelberger KJ, Chusid MJ. Dexamethasone therapy for bacterial meningitis. N Engl J Med 1989;320:464.
6. Sheth KJ, Gill JC, Havens PL, Leichter HE. Racial incidence of hemolytic-uremic syndrome. Pediatric Nephrology. 1995;9:401.
7. Banwart B, Splaingard ML, Farrell PM, Rock MJ, Havens PL, Moss J, Ehrmantraut ME, Frank DW, Barbieri JT. Children with cystic fibrosis produce an immune response against Exoenzyme S, a type-III cytotoxin of Pseudomonas aeruginosa. J Infect Dis 2002;185:269-70.
8. Havens PL, Roy B, Burr C. Providing for the care of HIV infected children, adolescents, and their families in the midwestern United States. Summary and proceedings of conference Feb 25, 1993.
9. Wisconsin Association for Perinatal Care. Position statement: Human immunodeficiency virus (HIV) education and testing in the perinatal period. July, 1995. Committee Co-chair.
10. Working Group on Antiretroviral Therapy and Medical Management of Infants, Children, and Adolescents with HIV Infection. Antiretroviral Therapy and Medical Management of Infants, Children, and Adolescents with HIV Infection. Pediatrics 1998;102:1005-1062. Also published as: Centers for Disease control and Prevention. Guidelines for the use of antiretroviral agents in pediatric HIV infection. MMWR 1998;47(RR-4). Current citation: Working Group on Antiretroviral Therapy and Medical Management of HIV-infected Children. Guidelines for the use of Antiretroviral Agents in Pediatric HIV Infection. Updated periodically at www.aidsinfo.nih.gov. Member of writing committee in 1996-1997, and again since 2000. Co-Chair 2003-2006. Co-Chair 2006 (Dec)-present. Contributed sections to versions published in: 1998, 2001, 2003, 2004, 2005, 2006, 2008, 2009, 2010.
11. American Academy of Pediatrics Committee on Pediatric AIDS. Education of children with human immunodeficiency virus infection. Pediatrics 2000;105:1358-60. Committee member
12. American Academy of Pediatrics Committee on Pediatric AIDS. Identification and care of HIV-exposed and HIV-infected infants, children, and adolescents in foster care. Pediatrics 2000;106:149-53. Committee member
13. Mofenson LM, and the American Academy of Pediatrics Committee on Pediatric AIDS. Technical report: Perinatal human immunodeficiency virus testing and prevention of transmission. Pediatrics 2000;106:e88. Committee member.
14. American Academy of Pediatrics Committee on Pediatric AIDS and Committee on Adolescence. Adolescents and human immunodeficiency virus infection: the role of the pediatrician in prevention and intervention. Pediatrics 2001;107:188-90. Committee member
15. Wisconsin Association for Perinatal Care. Revised Recommendations for Human immunodeficiency virus (HIV) education and testing in the perinatal period. September, 2002. Committee Co-chair.
16. Havens PL, and the American Academy of Pediatrics Committee on Pediatric AIDS. Clinical Report: Postexposure prophylaxis in children and adolescents for nonoccupational exposure to Human Immunodeficiency Virus. Pediatrics 2003;111:1475-1489. Primary author and committee member.
17. Read JS and the American Academy of Pediatrics Committee on Pediatric AIDS. Technical Report: Human Milk, breastfeeding, and transmission of human immunodeficiency virus type 1 in the United States. Pediatrics 2003;112:1196-1205. Committee Member
18. King SM, and the American Academy of Pediatrics Committee on Pediatric AIDS and the Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Evaluation and treatment of the human immunodeficiency virus-1-exposed infant. Pediatrics 2004;114:497-505. Committee member.
19. Human Immunodeficiency Virus Infection. First editor of this chapter for the "Red Book" 27th edition, American Academy of Pediatrics Report of the Committee on Infections Diseases. AAP, 2006. Committee chair.
20. Henry-Reid LM, and the American Academy of Pediatrics Committee on Pediatric AIDS. Reducing the risk of HIV infection associated with illicit drug use. Pediatrics 2006;117:566 Committee chair.
21. American Academy of Pediatrics Committee on Pediatric AIDS and Section on International Child Health. Havens PL, Gibb DM. Increasing antiretroviral drug access for children with HIV infection. Pediatrics 2007;119:838-845. Lead author and Committee chair.
22. American Academy of Pediatrics. "Covering the bases: Adolescent Sexual Health". 2007. "Pedialink" online educational tool (3 hours CME credit). Lead subject matter expert, lead author of section on sexually transmitted diseases in adolescents and Committee chair.
23. American Academy of Pediatrics Committee on Pediatic AIDS, Havens PL, Mofenson, LM,. Policy Statement. HIV Testing and Prophylaxis to Prevent Mother-to-Child Transmission in the United States. Pediatrics, Pediatrics 2008;122:1127-34. Lead author and committee chair
24. Havens PL, Mofenson LM, and the American Academy of Pediatrics Committee on Pediatric AIDS. Clinical Report: Evaluation and Management of the Infant Exposed to Human Immunodeficiency Virus Type 1 in the United States. Pediatrics, 2009;123:175-187. Lead author and committee chair
25. Mofenson LM, et al. Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the American Academy of Pediatrics. MMWR Recomm Rep 2009 Sep 4;58(RR-11):1-166. Committee member
26. Database for care of children and adolescents with HIV Infection, now in use in Wisconsin, and adapted for use in Chicago, New Hampshire, and Puerto Rico (Fall, 1997)
27. Havens PL. Bioterrorism: Background on three possible agents, available online: http://www.mcw.edu/peds/infectdis/bioterrorism.pdf. Included in the US Army Medical Department Center & School (AMEDDC&S), Academy Of Health Sciences, Fort Sam Houston, Texas, repository on Homeland Security, 2004
28. Havens PL. Smallpox Treatment 2002: Topic of Speculation, available online: http://ftp.cdc.gov/pub/infectious_diseases/iceid/2002/pdf/havens.pdf. Included in the US Army Medical Department Center & School (AMEDDC&S), Academy Of Health Sciences, Fort Sam Houston, Texas, repository on Homeland Security, 2004
 
Abstracts
1. Havens, PL: Group A streptococcal bacteremia in children. Ped Res 20 (4 pt. 2): 311A, 1986.
2. Havens PL, O'Rourke PP, Hahn J, Higgins J, and Walker AM. Predicting outcome in Hemolytic Uremic Syndrome. Presented to the American Academy of Pediatrics meetings, October 31, 1987, New Orleans, LA.
3. Hahn J, Havens PL, Higgins J, O'Rourke PP, and Estroff J. Neurologic Complications of Hemolytic Uremic Syndrome. Presented at Child Neurology Society Meetings, October, 1987.
4. Kelly KJ, Havens PL, Day SE, Hoffman GM, Deacon J, Wolf J. Extracorporeal Membrane Oxygenation (ECMO) in Two Infants with Congenital ECHO-11 Virus pneumonia. Presented at Ross Laboratories Special Conference. Two Great Debates in Neonatology, December 6-8, 1987, p. 137. Loews L'Enfant Plaza Hotel, Washington D.C., 1987.
5. Havens PL, Sowles PW, Sinner JA, Day SE. Gentamicin Pharmacokinetics of neonates receiving Extracorporeal Membrane Oxygenation. Presented at the CHNMC ECMO Symposium, February 21-28, 1988, Snowmass, Colorado.
6. Havens PL, Dunne WM, Sheth KJ. Neutralization of E. coli 0157:H7 Vero cell toxins by commercially available human intravenous immune globulin. Presented at the American Society for Microbiology Annual meeting, May 10, 1988, Miami, Florida.
7. Havens PL, Garland JS, Brook M, Dewitz B, Stremski E, Troshynski T. Trends in mortality and severity of meningococcal disease in children. Presented at the Interscience Conference on Antimicrobial Agents and Chemotherapy, October 23-26, l988 Los Angeles, California.
8. Leung DYM, Moake JL, Havens PL, Kim M, Pober JS. Lytic anti-endothelial cell antibodies are present in hemolytic-uremic syndrome (HUS) and differ from those in acute, non-relapsing thrombotic thrombocytopenic purpura (TTP). Clin Res, 36:413A. 1988.
9. Losek JD, Dewitz BA, Melzer-Lange M, Havens PL. Epiglottitis: signs and symptoms in children less than two years. Ped Res 1989;25:135A.
10. Garland J, Dunne W, Havens P, Hintermeyer M, Bozzette M, Wincek J, Bromberger T, Seavers M. Peripheral intravenous catheter (PVC) complications in children in a Pediatric Intensive Care Unit (PICU). Presented at 29th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 17-20 September 1989, Houston, Texas.
11. Dunne WM, Havens PL, Counter FT. Fibrinogen (FN) and proteolytic fragments of FN interfere with the adherence of slime-positive Staphylococcus epidermidis (S+SE) to plastic in vitro. Presented at 29th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 17-20 September 1989, Houston, Texas.
12. Havens PL, Moldovanu JC, Vaughan BC, Chusid MJ. Risk of late infection following transient candidemia. Presented at 29th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 17-20 September 1989, Houston, Texas.
13. Vaughan BC, Gill JC, Havens PL, Day SE. Association of the plasma anticoagulant, antithrombin III, and thrombosis following extracorporeal membrane oxygenation. Presented at the 3rd Pediatric Critical Care Colloquium, 26-28 October 1989, Santa Monica, California.
14. Havens PL, Dunne WM, and Burd EM. Effect of human intravenous immune globulin on diarrhea caused by shiga-like toxins I and II in infant rabbits. Presented at American Society for Microbiology Annual Meeting, May 13-17, 1990, Anaheim, California.
15. Torres A, Krilov LR, Jacobsen JM, Kelly KJ, and Havens PL. Reduction of occupational exposure to Ribavirin using a simple scavenging system. Presented at the 4th Pediatric Critical Care Colloquium, 2-4 October, 1990, Waterville Valley, New Hampshire.
16. Havens PL, Butler JC, Day SE, Mohr BA, and Chusid MJ. Characteristics of 243 children hospitalized with measles during an epidemic in Milwaukee. Presented at 30th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 21-24 October, 1990, Atlanta, GA.
17. Krilov L, Torres A, Jacobsen J, Karol M, Kelly K, and Havens PL. A double hood system to prevent escape of ribavirin. Presented at 30th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 21-24 October, 1990, Atlanta, GA.
18. Burd EM, Havens PL, Dunne WM. Enzyme linked immunosorbent assay (ELISA) for Shiga-like toxin II based on its binding to the receptor globotriosyl ceramide (Gb3). Presented at the American Society for Microbiology Annual Meeting, May 5-9, 1991, Dallas, TX.
19. Sachdeva RC, Day SE, Havens PL, Weitekamp LA, Vaughan BC. Effect of a protocol to minimize blood donor exposure (DE) in ECMO patients. Presented at the Seventh Annual Children's Hospital National Medical Center ECMO Symposium, February, 1991, Breckenridge, CO.
20. Havens PL, Burd EM, and Dunne WM. Prevalence of antibody to Shiga-like toxins I and II varies by age and location. Presented at 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 29 September - 2 October, 1991, Chicago, IL.
21. Butler JC, Havens PL, Sowell A, Day SE, Chusid MJ, Peterson DE, Markowitz LE, and Davis JP. Measles severity and serum vitamin A levels. Presented at 31st Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), 29 September - 2 October, 1991, Chicago, IL.
22. Gedeit R, Weigle C, Werlin S, and Havens P. Ranitidine and control of gastric pH in critically ill children. Presented at the 5th Pediatric Critical Care Colloquium, Snowbird, Utah, January 26-30, 1992.
23. Bresnahan J, Babel K, Splaingard M, and Havens PL. Survival and functional outcome of children requiring assisted ventilation during therapy for acute bacterial meningitis. Presented at the 5th Pediatric Critical Care Colloquium, Snowbird, Utah, January 26-30, 1992.
24. Kelly KJ, Kurup VP, Resnick A, Fink JN, Roberts M, Grammer L, and Havens PL. A case control study of hypersensitivity to latex, ethylene oxide, and allergic factors predicting anaphylaxis in pediatric patients undergoing general anesthesia. Presented at the American Academy of Allergy and Immunology Annual Meeting, Orlando, Florida, March 8, 1992.
25. McAuliffe J, Wendelberger KJ, Havens PL. Predicting need for resuscitation in hospitalized pediatric patients. Presented at the American Academy of Pediatrics Fall Meetings, Section on Critical Care, San Francisco, CA, October 10-15, 1992.
26. Torres A, Hoffman GM, Werlin SL, Walker L, Cochran J, Reddy MN, Havens PL. Persistent catabolism despite increased anabolic hormone production in critically ill children. Presented at the Pediatric Critical Care Colloquium, Phildelphia, PA, March 28-31, 1993.
27. Hoffman GM, Torres A, Havens PL, Walker L, Reddy MN, Werlin SL. High RQ does not indicate anabolic state in critically ill patients. Presented at the Pediatric Critical Care Colloquium, Phildelphia, PA, March 28-31, 1993. Published in Anesthesiology 1993;79(3A):A264.
28. Thakker J, Kim J, Splaingard M, Babel K, Bresnahan J, Havens PL. Survival and functional outcome in children with severe traumatic brain injury. Presented at the Pediatric Critical Care Colloquium, Phildelphia, PA, March 28-31, 1993.
29. Sachdeva RC, Torres A, Person AD, Oddo CT, Sabnis SS, Montano ST, Rimm AA, Havens PL. Early predictors of prolonged PICU stay. Presented at the Pediatric Critical Care Colloquium, Phildelphia, PA, March 28-31, 1993.
30. Cochran J, Palmisano B, Havens PL, Weigle C. Comparison of heart rate variability in healthy pre-operative patients and patients in PICU. Presented at the Pediatric Critical Care Colloquium, Phildelphia, PA, March 28-31, 1993.
31. Yabut B, Werlin S, Havens P, Bohorfoush. The role of ERCP in Pediatric AIDS. Submitted to the North American Society for Pediatric Gastroenterology and Nutrition Meeting, Houston, TX, Oct 10-12, 1994.
32. Kehl KS, Havens P, Chusid MJ. Sensitivity of BacTec blood culture method for the detection of positives at two days. Presented at the 94th General Meeting of the American Society for Microbiology. Las Vegas, Nevada. May 23-27, 1994.
33. Kehl KS, Cicirello H, Havens P. Comparison of methods for the detection of cryptosporidium in children. Presented at the 94th General Meeting of the American Society for Microbiology. Las Vegas, Nevada. May 23-27, 1994.
34. Cuene BE, Havens PL, Kovnar SG, Marquardt KM. Wisconsin HIV Primary Care Support Network. Presentation at the Seventh Annual Conference of the Association of Nurses in AIDS Care, November 10-12, 1994. Nashville, TN.
35. Spack L, Griffith O, Havens PL, Narayanan K. Effects of nitric oxide synthase inhibitors on blood pressure in rats. Presented at the Pediatric Critical Care Colloquium, Seattle, WA, October 26-29, 1994.
36. Spack L, Gedeit R, Havens P, Splaingard M. Failure of aggressive therapy to alter outcome in pediatric near drowning. Presented at the Pediatric Critical Care Colloquium, Seattle, WA, October 26-29, 1994.
37. Havens PL, Waters D, Hand J. Children's Hospital of Wisconsin Pediatric and Adolescent HIV Care Program. Presented at National Association of Children's Hospitals and Related Institutions (NACHRI) Annual Meeting, October 5-7, 1994. Salt Lake City, UT.
38. Havens PL, Cuene BE, Waters D, Marquardt KM, Hand JR, Chusid MJ. Effectiveness of a primary provider-based program for care of children with HIV infection. Presented at the Second National Conference on Human Retroviruses and Related Infections, Washington, DC. Jan 29 - Feb 2, 1995.
39. Kehl KS, Behnke C, Havens P. Development of cost effective enteric pathogen testing based on surveillance, patient location, and season. Presented at the American Society of Microbiology Annual Meeting, Washington, D.C. May 21-25, 1995.
40. Kehl KS, Proctor M, Mellen J, Havens P. Culture for E. coli O157:H7 and testing for Shiga-like toxin during an outbreak of diarrhea in a daycare center. Presented at the American Society of Microbiology Annual Meeting, Washington, D.C. May 21-25, 1995.
41. Ross GA, Hoffman GM, Wendelberger KJ, Nelin LD, Day SE, Weigle CGM, Rice TB, Havens, PL. Availability of nitric oxide inhalation therapy reduces use of extracorporeal membrane oxygenation (ECMO) as therapy for severe neonatal respiratory failure. Presented at the Pediatric Critical Care Colloquium, October 2-4, 1995, South Carolina.
42. Spack LC, Griffith O, Havens PL, Brazovich L. Serum nitrite/nitrate concentrations in pediatric patients with the systemic inflammatory response syndrome (SIRS). Presented at the Pediatric Critical Care Colloquium, October 2-4, 1995, South Carolina.
43. Havens PL, Cuene BE, Hand JR. Lifetime cost of care for children with HIV infection. Presented at the Third Conference on Retroviruses and Opportunistic Infections, Jan 28-Feb 1, 1996, Washington, DC.
44. Cuene BE, Havens PL, Hanlon-Lundberg K, Hand JR, Reiser W, Vergeront J. Universal HIV Counseling and Voluntary Testing for pregnant women: an educational strategy for implementation in a low HIV prevalence, rural state. Presented at the Ninth Annual Association of Nurses in AIDS Care Conference, Oct 31-Nov 3, 1996, Chicago, IL.
45. Balasubramanyan N, Havens PL, Hoffman GM. Fencl-Stewart acid-base method compared with base excess/anion gap method in PICU patients. Presented at American Society of Anesthesiologists Annual Meeting, Oct 1996, New Orleans, LA.
46. Havens PL, Cuene BE. Effectiveness of Perinatally Administered Zidovudine (ZDV) in Decreasing Vertical Transmission of HIV Infection in Wisconsin. Presented at the Fourth Conference on Retroviruses and Opportunistic Infections, Jan 22-26, 1997, Washington, DC.
47. Havens PL, Cuene BE. Impact of an Educational Program to Change Provider Practice Concerning HIV Counseling and Testing of Pregnant Women. Presented at the Fourth Conference on Retroviruses and Opportunistic Infections, Jan 22-26, 1997, Washington, DC.
48. Balasubramanyan N, Havens PL, Hoffman GM. Fencl-Stewart Acid-Base Method Predicts Lactic Acidosis Better than Standard Methods in Pediatric Intensive Care Unit Patients. Presented at the 26th Educational and Scientific Symposium, Society of Critical Care Medicine, Feb 6-10, 1997, San Diego, CA.
49. Havens PL, Cuene BE, for the HIV Research Consortium for Children, Youth, Women, and Families. Effects of Parent and Provider Attitude on Frequency of Use of Protease Inhibitors in Children and Adolescents with HIV Infection. Presented at the Ryan White Title IV Demonstration Projects Annual Meeting, Washington, D.C., Nov 17-18, 1997.
50. Havens PL, Cuene BE, for the HIV Research Consortium for Children, Youth, Women, and Families. Safety and Efficacy of Protease Inhibitor Therapy in Children and Adolescents with HIV Infection. Presented at the Ryan White Title IV Demonstration Projects Annual Meeting, Washington, D.C., Nov 17-18, 1997.
51. Havens PL, Cuene BE, for the HIV Research Consortium for Children, Youth, Women, and Families. Efficacy of Protease Inhibitor Therapy in Children and Adolescents with HIV Infection. Presented at 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Sept 24-27, 1998, San Diego, CA.
52. Beckmann KR, Havens PL, Cuene BE, Dietz M, Melzer-Lange M. The Effectiveness of a call-back program at increasing human immunodeficiency virus (HIV) testing in a pediatric emergency department. Presented at the Ambulatory Pediatric Association Annual Meeting, 1999.
53. Bower DJ, Havens PL, Derse AR, Autry AM. Ethical Dilemmas: Pregnancy Care for an HIV-positive woman who refuses Treatment for herself and her newborn. Medical College of Wisconsin Department of Family and Community Medicine 8th Research Forum, June 7, 1999. Milwaukee, WI.
54. Meyer MT, Berens RJ, Havens PL. Association of the Nursing Assessment of Withdrawal with the Neonatal Abstinence Score. Presented at the Pediatric Critical Care Colloquium, Sept. 22-26, 1999, Portland. OR. Published in Clin Intensive Care 1999;10:151.
55. Meyer MT, Berens RJ, Havens PL. Association of the Nursing Assessment of Withdrawal with the Neonatal Abstinence Score. Presented at the Society of Critical Care Medicine Annual Meeting, Feb 11-15, 2000, Orlando, FL.
56. Peter LD, Hancock B, Ivantec-Doucette K, Barabe D, Havens PL. Outcome evaluation of a Title 4 Women's Support Program. Ryan White Care Act Grantee Conference, Washington, DC. Aug 30-23, 2002.
57. Skoumal KS, Splaingard ML, Crowe MJ, Gennarelli TA, Havens PL. Apolipoprotein E epsilon 4 in pediatric traumatic brain injury: Phase I-Difficulty in obtaining approvals and patient enrollment. Presented at the First Joint Symposium of the National and International Neurotrauma Societies, November, 2002.
58. Rao AR, Splaingard MS, Gershan WM, Havens PL, Barbieri JT. Pseudomonas Type-III antibody detection in children with tracheostomies. Presented at the American Thoracic Society 100th International Conference, May 21 to 26, 2004, Orlando, FL
59. Havens P, Frank M, Cuene B, Decker V, Kohler R, Wolfe A, Yenter M. Pharmacokinetics and safety of lopinavir/ritonavir doses greater than 300 mg/m2/dose in children and adolescents with HIV infection. Presented at the 11th Conference on Retroviruses and Opportunistic Infections, Feb 8-11, 2004, San Francisco, CA.
60. Lee KJ, Havens PL, Hoffman GM, Sato TT, Leuthner SR. Pediatric Assent - Clinician Knowledge, Attitudes, and practice. Pediatric Academic Societies Annual Meeting, May 1-4, 2004, San Francisco, CA
61. Tieves KS, Musynski CA, Kaufman, BA, Havens PL. Changes in the outcome of pediatric patients with severe traumatic brain injury over time.Pediatric Critical Care Colloquium Sept. 30-Oct 2, 2004, New York, New York; Society of Critical Care Medicine Symposium Jan 15-19, 2005.
62. Tieves KS, Scanlon MC, Rice TB, Havens PL. Outcome of pediatric patients with head injury: Center differences in mortality and functional outcome at PICU discharge. Pediatric Critical Care Colloquium Sept. 30-Oct 2, 2004, New York, New York.
63. Tieves KS, Muszynski CA, Kaufman BA, Havens PL, Thakker JC. Changes in the outcome of pediatric patients with severe traumatic brain injury over time. Crit Care Med Vol. 32, No. 12 (Supp): A101 Presented at SCCM 34th Critical Care Congress Jan. 15-19, 2005. Phoenix, AZ
64. Punzalan R, *Hanson S, Ghanayem N, Havens PL. The prevalence of heparin dependent antibodies in children after cardiopulmonary bypass. Presented at the American Society of Hematology Meeting, December, 2005.
65. Hanson S, Ghanayem N, Punzalan R, Havens PL. The prevalence of heparin dependent antibodies in children after cardiopulmonary bypass. Presented at the AATS meeting, Spring, 2006.
66. Skelton JA, Mullin S, Otto M, Mao J, Havens PL. Body mass index distribution in a tertiary care constipation clinic. Presented at NASPGHAN 2005 annual meeting.
67. Persaud D, Havens PL, Palumbo R, Chadwick E. Acquisition and archiving of non-nucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1 variants during mother to child transmission in U.S. born infants. Presented at the 12th Conference on Retroviruses and Opportunistic Infections, Feb 5-9, 2006, Denver, CO
68. O'Connor KG, Havens PL, Henry-Reid L, Lindros J, Klein JD, Futterman D. Discussing high-risk behaviors with adolescents: Results of a national survey of pediatricians. Accepted to the American Public Health Association Meeting, November, 2006.
69. Stolzman SC, *Skelton JA, Irwin N, Hackbarth H, Mao J, Havens PL. Musculoskeletal and exercise limitations in an overweight population. Presented at the Pediatric Academic Societies Meeting, May, 2006.
70. Robbins B, Havens PL, Capparelli E, Chadwick E, Yogev R, Serchuck L, Aldronvandi G, Alvero C, Heckman B, Rodman J and PACTG 1038 Team. Pharmacokinetics (PK) of high-dose lopinavir (LPV)/ritonavir ® with and without saquinavir (SQV) or non-nucleoside reverse transcriptase inhibitors (NNRTIs) in HIV infected pediatric and adolescent patients previously treated with protease inhibitors (PI). Submitted to the 14th Conference on Retroviruses and Opportunistic Infections, Los Angeles, California, 2007.
71. Kiser JJ, Fletcher CV, Flynn P, Cunningham CK, Wilson CM, Kapogiannis B, Major-Wilson H, Viani RM, Muenz L, Harris DR, Havens PL, and the Adolescent Trials Network for HIV/AIDS Intervention. Pharmacokinetics of antiretroviral regimens containing Tenofovir Disoproxil Fumarate (TDF) and Atazanavir/Ritonavir (ATV/RTV) in adolescents and young adults with HIV infection - Study ATN056. 8th International Workshop on Clinical Pharmacology of HIV Therapy, Budapest, Hungary, April 16-18, 2007, abstract 12
72. Franklin JA, Lim HJ, Havens PL. Longitudinal academic and social progress of children with perinatally acquired HIV. Presented at the Annual Convention of the American Psychological Association, San Francisco, CA, Aug 18, 2007
73. Hanson SJ, Punzalan R, Greenup R, Lui H, Sato TT, Havens PL, "Risk Factors for Venous Thromboembolism in Critically Ill Children after Trauma". Presented at 17th Pediatric Critical Care Colloquium, February 2008, Whistler, Canada.
74. Hanson SJ, Havens PL, Wells R, "Comparison of Intrapleural Alteplase Fibrinolysis vs. Normal Saline Irrigation on Parapneumonic Effusion Drainage Volume in Children." Accepted for poster presentation at American Thoracic Society, May 2008, Toronto,Canada.
 

jenkins-FCD Prod-403 0f9a74600e4e79798f8fa6f545ea115f3dd948b2